掲載種別：研究論文（学術雑誌）   出版者・発行元：Pharmaceutical Society of Japan  

DOI： 10.1248/bpb.b22-00112

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：{MDPI} {AG}  

Triple-negative breast cancer (TNBC) is a highly aggressive cancer for which targeted therapeutic agents are limited. Growing evidence suggests that TNBC originates from breast cancer stem cells (BCSCs), and elucidation of the molecular mechanisms controlling BCSC proliferation will be crucial for new drug development. We have previously reported that the lysosphingolipid sphingosine-1-phosphate mediates the CSC phenotype, which can be identified as the ALDH-positive cell population in several types of human cancer cell lines. In this study, we have investigated additional lipid receptors upregulated in BCSCs. We found that lysophosphatidic acid (LPA) receptor 3 was highly expressed in ALDH-positive TNBC cells. The LPAR3 antagonist inhibited the increase in ALDH-positive cells after LPA treatment. Mechanistically, the LPA-induced increase in ALDH-positive cells was dependent on intracellular calcium ion (Ca2+), and the increase in Ca2+ was suppressed by a selective inhibitor of transient receptor potential cation channel subfamily C member 3 (TRPC3). Moreover, IL-8 production was involved in the LPA response via the activation of the Ca2+-dependent transcriptional factor nuclear factor of activated T cells. Taken together, our findings provide new insights into the lipid-mediated regulation of BCSCs via the LPA-TRPC3 signaling axis and suggest several potential therapeutic targets for TNBC.

DOI： 10.3390/ijms23041967

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Wiley  

Amino acid derivative reactivity assay (ADRA) for skin sensitization was adopted as an alternative method in the 2019 OECD Guideline for the Testing of Chemicals (OECD TG 442C). The molar ratio of the nucleophilic reagent to the test chemicals in the reaction solution was set to 1:50. Imamura et al. reported that changing this molar ratio from 1:50 to 1:200 reduced in false negatives and improved prediction accuracy. Hence, a ring study using ADRA with 4 mM of a test chemical solution (ADRA, 4 mM) was conducted at five different laboratories to verify within- and between-laboratory reproducibilities (WLR and BLR, respectively). In this study, we investigated the WLR and BLR using 14 test chemicals grouped into three classes: (1) eight proficiency substances, (2) four test chemicals that showed false negatives in the ADRA with 1 mM test chemical solution (ADRA, 1 mM), but correctly positive in ADRA (4 mM), and (3) current positive control (phenylacetaldehyde) and a new additional positive control (squaric acid diethyl ester). The results showed 100% reproducibility and 100% accuracy for skin sensitization. Hence, it is clear that the ADRA (4 mM) is an excellent test method in contrast to the currently used ADRA (1 mM). We plan to resubmit the ADRA (4 mM) test method to the OECD Test Guideline Group in the near future so that OECD TG 442C could be revised for the convenience and benefit of many ADRA users.

DOI： 10.1002/jat.4268

PubMed

researchmap

その他リンク： https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jat.4268

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Predicting drug-induced cardiotoxicity during the non-clinical stage is important to avoid severe consequences in the clinical trials of new drugs. Human iPSC-derived cardiomyocytes (hiPSC-CMs) hold great promise for cardiac safety assessments in drug development. To date, multi-electrode array system (MEA) has been a widely used as a tool for the assessment of proarrhythmic risk with hiPSC-CMs. Recently, new methodologies have been proposed to assess in vitro contractility, such as the force and velocity of cell contraction, using hiPSC-CMs. Herein, we focused on an imaging-based motion vector system (MV) and an electric cell-substrate impedance sensing system (IMP). We compared the output signals of hiPSC-CMs from MV and IMP in detail and observed a clear correlation between the parameters. In addition, we assessed the effects of isoproterenol and verapamil on hiPSC-CM contraction and identified a correlation in the contractile change of parameters obtained with MV and IMP. These results suggest that both assay systems could be used to monitor hiPSC-CM contraction dynamics.

DOI： 10.1016/j.vascn.2022.107227

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Evaluation of drug-induced cardiotoxicity is still challenging to avoid adverse effects, such as torsade de pointes (TdP), in non-clinical and clinical studies. Numerous studies have suggested that human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a useful platform for detecting drug-induced TdP risks. Comprehensive in vitro Proarrhythmia Assay (CiPA) validation study suggested that hiPSC-CMs can assess clinical TdP risk more accurately than the human ether-a-go-go-related assay and QT interval prolongation. However, there were still some outliers, such as bepridil, mexiletine, and ranolazine, among the CiPA 28 compounds in the CiPA international multi-site study using hiPSC-CMs. In this study, we assessed the effects of the positive compound dofetilide, the negative compound aspirin, and several CiPA compounds (bepridil, mexiletine, and ranolazine) on the electromechanical window (E-M window), which were evaluated using multi-electrode array assay and motion analysis, in hiPSC-CMs. Similar to previous in vivo studies, dofetilide, which has a high TdP risk, decreased the E-M window in hiPSC-CMs, whereas aspirin, which has a low TdP risk, had little effect. Bepridil, classified in the high TdP-risk group in CiPA, decreased the E-M window in hiPSC-CMs, whereas ranolazine and mexiletine, which are classified in the low TdP-risk group in CiPA, slightly decreased or had little effect on the E-M window of hiPSC-CMs. Thus, the E-M window in hiPSC-CMs can be used to classify drugs into high and low TdP risk.

DOI： 10.1248/bpb.b22-00268

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Oxford University Press ({OUP})  

Coronavirus disease 2019 (COVID-19) continues to spread across the globe, with numerous clinical trials underway seeking to develop and test effective COVID-19 therapies, including remdesivir. Several ongoing studies have reported hydroxychloroquine-induced cardiotoxicity, including development of torsade de pointes (TdP). Meanwhile, human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are expected to serve as a tool for assessing drug-induced cardiotoxicity, such as TdP and contraction impairment. However, the cardiotoxicity of COVID-19 treatments has not been fully assessed using hiPSC-CMs. In this study, we focused on drug repurposing with various modes of actions and examined the TdP risk associated with COVID-19 treatments using field potential using multi-electrode array system and motion analysis with hiPSC-CMs. Hydroxychloroquine induced early after depolarization, while remdesivir, favipiravir, camostat, and ivermectin had little effect on field potentials. We then analyzed electromechanical window, which is defined as the difference between field potential and contraction-relaxation durations. Hydroxychloroquine decreased electromechanical window of hiPSC-CMs in a concentration-dependent manner. In contrast, other drugs had little effect. Our data suggest that hydroxychloroquine has proarrhythmic risk and other drugs have low proarrhythmic risk. Thus, hiPSC-CMs represent a useful tool for assessing the comprehensive cardiotoxicity caused by COVID-19 treatments in nonclinical settings.

DOI： 10.1093/toxsci/kfab079

PubMed

researchmap

掲載種別：研究論文（学術雑誌）   出版者・発行元：Elsevier BV  

DOI： 10.1016/j.yrtph.2021.104963

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Growing evidence suggests that breast cancer originates from a minor population of cancer cells termed cancer stem cells (CSCs), which can be identified by aldehyde dehydrogenase (ALDH) activity-based flow cytometry analysis. However, novel therapeutic drugs for the eradication of CSCs have not been discovered yet. Recently, drug repositioning, which finds new medical uses from existing drugs, has been expected to facilitate drug discovery. We have previously reported that sphingosine kinase 1 (SphK1) induced proliferation of breast CSCs. In the present study, we focused on the immunosuppressive agent FTY720 (also known as fingolimod or Gilenya), since FTY720 is known to be an inhibitor of SphK1. We found that FTY720 blocked both proliferation of ALDH-positive cells and formation of mammospheres. In addition, we showed that FTY720 reduced the expression of stem cell markers such as Oct3/4, Sox2 and Nanog via upregulation of protein phosphatase 2A (PP2A). These results suggest that FTY720 is an effective drug for breast CSCs in vitro.

DOI： 10.3390/ijms22147259

PubMed

researchmap

掲載種別：研究論文（学術雑誌）   出版者・発行元：Elsevier BV  

DOI： 10.1016/j.fct.2021.112206

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Wiley  

The Amino acid Derivative Reactivity Assay (ADRA) is a convenient and effective in chemico test method for assessing covalent binding of test chemicals with protein-derived nucleophilic reagents as a means of predicting skin sensitization potential. Although the original molar-concentration approach to ADRA testing was not suitable for testing multiconstituent substances of an unknown composition, a weight-concentration approach that is suitable for such substances was developed, which also led to the realization that test chemical solutions prepared to molar concentrations higher than the original 1 mM would reduce false negative results as well as enhance predictive capacity. The present study determined an optimal molar-concentration that achieves even higher predictive capacity than the original ADRA. Eight chemicals that were false negatives when tested with 1 mM test chemical solutions were retested with test chemical solutions between 2 and 5 mM, which showed 4 mM to be the optimal molar-concentration for ADRA testing. When 82 chemicals used in the original development were retested with 4 mM test chemical solutions, false negative results were reduced by four. When an additional 85 chemicals used to evaluate the weight-concentration approach to ADRA were retested, the results essentially replicated those obtained with 0.5 mg/ml test chemical solutions and gave 10 fewer false negatives than original ADRA with 1 mM solutions. A comparison of these results for 136 chemicals showed that ADRA testing with 4 mM solutions achieved a four percentage point improvement in accuracy over original ADRA and a two percentage point improvement over DPRA testing.

DOI： 10.1002/jat.4082

PubMed

researchmap

その他リンク： https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jat.4082

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Japanese Society of Toxicology  

Predicting drug-induced side effects in the cardiovascular system is very important because it can lead to the discontinuation of new drugs/candidates or the withdrawal of marketed drugs. Although chronic assessment of cardiac contractility is an important issue in safety pharmacology, an in vitro evaluation system has not been fully developed. We previously developed an imaging-based contractility assay system to detect acute cardiotoxicity using human iPS cell-derived cardiomyocytes (hiPSC-CMs). To extend the system to chronic toxicity assessment, we examined the effects of the anti-hepatitis C virus (HCV) drug candidate BMS-986094, a guanosine nucleotide analogue, which was withdrawn from phase 2 clinical trials because of unexpected contractility toxicities. Additionally, we examined sofosbuvir, another nucleotide analogue inhibitor of HCV that has been approved as an anti-HCV drug. Motion imaging analysis revealed the difference in cardiotoxicity between the cardiotoxic BMS-986094 and the less toxic sofosbuvir in hiPSC-CMs, with a minimum of 4 days of treatment. In addition, we found that BMS-986094-induced contractility impairment was mediated by a decrease in calcium transient. These data suggest that chronic treatment improves the predictive power for the cardiotoxicity of anti-HCV drugs. Thus, hiPSC-CMs can be a useful tool to assess drug-induced chronic cardiotoxicity in non-clinical settings.

DOI： 10.2131/jts.46.359

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Wiley  

The amino acid derivative reactivity assay (ADRA), which is an in chemico alternative to the use of animals in testing for skin sensitization potential, offers significant advantages over the direct peptide reactivity assay (DPRA) in that it utilizes nucleophilic reagents that are sensitive enough to be used with test chemical solutions prepared to concentrations of 1 mm, which is one-hundredth that of DPRA. ADRA testing of hydrophobic or other poorly soluble compounds requires that they be dissolved in a solvent consisting of dimethyl sulfoxide (DMSO) and acetonitrile. DMSO is known to promote dimerization by oxidizing thiols, which then form disulfide bonds. We investigated the extent to which DMSO oxidizes the cysteine-derived nucleophilic reagents used in both DPRA and ADRA and found that oxidation of both N-(2-(1-naphthyl)acetyl)-l-cysteine (NAC) and cysteine peptide increases as the concentration of DMSO increases, thereby lowering the concentration of the nucleophilic reagent. We also found that use of a solvent consisting of 5% DMSO in acetonitrile consistently lowered NAC concentrations by about 0.4 μm relative to the use of solvents containing no DMSO. We also tested nine sensitizers and four nonsensitizers having different sensitization potencies to compare NAC depletion with and without 5% DMSO and found that reactivity was about the same with either solvent. Based on the above, we conclude that the use of a solvent containing 5% DMSO has no effect on the accuracy of ADRA test results. We plan to review and propose revisions to OECD Test Guideline 442C based on the above investigation.

DOI： 10.1002/jat.3948

PubMed

researchmap

その他リンク： https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jat.3948

掲載種別：研究論文（学術雑誌）   出版者・発行元：Elsevier BV  

DOI： 10.1016/j.yrtph.2019.104482

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

The amino acid derivative reactivity assay (ADRA) is an in chemico alternative method that focuses on protein binding as the molecular initiating event for skin sensitization. It is a simple and versatile method that has successfully solved some of the problems of the direct peptide reactivity assay (DPRA). The transferability and within- and between-laboratory reproducibility of ADRA were evaluated and confirmed as part of a validation study conducted at four participating laboratories. The transfer of ADRA technology from the lead laboratory to the four participating laboratories was completed successfully during a two-step training program, after which the skin sensitization potentials of 40 coded chemicals were predicted based on the results of ADRA testing. Within-laboratories reproducibility was 100% (10 of 10), 100% (10 of 10), 100% (7 of 7) and 90% (9 of 10), or an average of 97.3% (36 of 37); between-laboratory reproducibility as calculated on the results of three laboratories at the time was 91.9%. The overall predictive capacity comprised an accuracy of 86.9%, sensitivity of 81.5% and specificity of 98.1%. These results satisfied the targets set by the validation management team for demonstrating transferability, within- and between-laboratory reproducibility, and predictive capacity as well as gave a clear indication that ADRA is easily transferable and sufficiently robust to be used in place of DPRA.

DOI： 10.1002/jat.3834

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Wiley  

The amino acid derivative reactivity assay (ADRA) is an in chemico alternative assay for skin sensitization listed in OECD test guideline 442C. ADRA evaluates the reactivity of sensitizers to proteins, which is key event 1 in the skin sensitization adverse outcome pathway. Although the current key event 1 evaluation method is a simple assay that evaluates nucleophile and test chemical reactivity, mixtures of unknown molecular weights cannot be evaluated because a constant molar ratio between the nucleophile and test chemical is necessary. In addition, because the nucleophile is quantified by HPLC, the frequency of co-eluting the test chemical and nucleophile increases when measuring multi-component mixtures. To solve these issues, test conditions have been developed using a 0.5 mg/mL test chemical solution and fluorescence-based detection. Since the practicality of these methods has not been substantiated, a validation test to confirm reproducibility was conducted in this study. The 10 proficiency substances listed in the ADRA guidelines were tested three times at five different laboratories. The results of both within- and between-laboratory reproducibility were 100%, and the results of ultraviolet- and fluorescence-based measurements were also consistent. In addition to the proficiency substances, a new positive control, squaric acid diethyl ester, was tested three times at the five laboratories. The results showed high reproducibility with N-(2-(1-naphthyl)acetyl)-l-cysteine depletion of 37%-52% and α-N-(2-(1-naphthyl)acetyl)-l-lysine depletion of 99%-100%. Thus, high reproducibility was confirmed in both evaluations of the 0.5 mg/mL test chemical and the fluorescence-based measurements, validating the practicability of these methods.

DOI： 10.1002/jat.3834

PubMed

researchmap

その他リンク： https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jat.3834

掲載種別：研究論文（学術雑誌）   出版者・発行元：Elsevier {BV}  

DOI： 10.1016/j.vascn.2019.01.001

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Wiley  

The amino acid derivative reactivity assay (ADRA) is an in chemico alternative to animal testing for skin sensitization that solves certain problems found in the use of the direct peptide reactivity assay (DPRA). During a recent validation study conducted at multiple laboratories as part of the process to include ADRA in an existing OECD test guideline, one of the nucleophilic reagents used in ADRA-N-(2-(1-naphthyl)acetyl)-l-cysteine (NAC)-was found to be susceptible to oxidation in much the same manner that the cysteine peptide used in DPRA was. Owing to this, we undertook a study to clarify the cause of the promotion of NAC oxidation. In general, cysteine and other chemicals that have thiol groups are known to oxidize in the presence of even minute quantities of metal ions. When metal ions were added to the ADRA reaction solution, Cu2+ promoted NAC oxidation significantly. When 0.25 μm of EDTA was added in the presence of Cu2+ , NAC oxidation was suppressed. Based on this, we predicted that the addition of EDTA to the NAC stock solution would suppress NAC oxidation. Next, we tested 82 chemicals used in developing ADRA to determine whether EDTA affects ADRA's ability to predict sensitization. The results showed that the addition of EDTA has virtually no effect on the reactivity of NAC with a test chemical, yielding an accuracy of 87% for predictions of skin sensitization, which was roughly the same as ADRA.

DOI： 10.1002/jat.3707

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Japanese Society of Toxicology  

Amino acid derivative reactivity assay (ADRA) has previously been developed as an alternative method to direct peptide reactivity assay (DPRA) to evaluate key event 1 in skin sensitization mechanisms. However, when using alternative methods for skin sensitization, integrated approaches to testing and assessment (IATA) that combine the results of multiple tests evaluating different key events are generally required. To verify whether ADRA can be used in IATA, we replaced DPRA with ADRA in five IATA methods combining DPRA, KeratinoSens, and h-CLAT: (i) the “2 out of 3” approach, (ii) the “3 out of 3” approach, (iii) sequential testing strategy (STS), (iv) integrated testing strategy by scoring approach (ITS-SA), and (v) the “ITS by two methods approach” (ITS-2MA). The prediction accuracy of the “2 out of 3” approach using ADRA (1 mM) and ADRA (0.5 mg/mL) was 90.0% and 91.1%, respectively, for human data, and was very similar to that obtained using DPRA (91.1%). The “3 out of 3” approach also showed good predictability (83.2%) using either ADRA (1 mM) or ADRA (0.5 mg/mL) compared to DPRA. Regarding the accuracy of the prediction of sensitization intensity for the human data by the third classification, prediction accuracy using ADRA was almost the same as STS, ITS-SA, or ITS-2MA using DPRA. As a result, this study showed that ADRA can be used as a test method for key event 1 in the evaluation of skin sensitization by combining multiple alternative methods.

DOI： 10.2131/jts.44.585

PubMed

CiNii Article

CiNii Books

researchmap

掲載種別：研究論文（学術雑誌）   出版者・発行元：Food Safety Commission, Cabinet Office  

DOI： 10.14252/foodsafetyfscj.2018017

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：Academic Press Inc.  

4-Benzylphenol (CAS No. 101-53-1), a structural analog of bisphenol F, has estrogenic activity in vitro and in vivo, as is the case with bisphenol F. 4-Benzylphenol is used in plastics and during organic synthesis. Since its safety is largely unknown, we conducted toxicity tests as part of screening risk assessment in an existing chemical safety survey program. Based on results of the Ames test and the chromosomal aberration test using Chinese hamster lung cells (OECD TG 471 and 473), 4-benzylphenol was determined to be non-genotoxic in vitro. In a 28-day repeated-dose toxicity study, Crl:CD (SD) rats were administrated 4-benzylphenol by gavage at 0, 30, 150, or 750 mg/kg/day (OECD TG 407). Consequently, body weight was lower in males at 750 mg/kg/day. In the liver, relative organ weights were increased in both sexes at 750 mg/kg/day, and centrilobular hepatocellular hypertrophy was observed in males at 150 and 750 mg/kg/day. In the forestomach, hyperkeratosis and hyperplasia of squamous cells were observed in males at 150 and 750 mg/kg/day, and in females at 750 mg/kg/day. Based on these results, we identified the NOAEL for 4-benzylphenol as 30 mg/kg/day, with a hazard assessment value (D-value) of 0.05 mg/kg/day corresponding to hazard class 3.

DOI： 10.1016/j.yrtph.2018.04.017

Scopus

researchmap

掲載種別：研究論文（学術雑誌）   出版者・発行元：Food Safety Commission, Cabinet Office  

DOI： 10.14252/foodsafetyfscj.2017023

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

2-(2'-Hydroxy-3',5'-di-tert-butylphenyl)benzotriazole (HDBB), the Benzotriazole UV-stabilizer (BUVSs) known as UV-320, is widely used in plastic materials for protection against UV-irradiation. Previously, we reported that oral ingestion of HDBB induce hepatotoxicity including hepatocyte hypertrophy and necrosis in rats and, males was more susceptible compared with females in young rats while no sex-related difference was observed in preweaning rats. Phenotypes observed in our previous study imply involvement of peroxisome proliferator-activated receptor (PPAR) alpha in HDBB hepatotoxicity, however, direct evidence that HDBB can activate PPAR alpha has not been provided and the mechanism which underlying the gender difference of HDBB hepatotoxicity was not clearly elucidated. Here, we conduct transcriptome analysis using microarray expression profiles in the livers of rats administered HDBB. PPAR alpha agonist activity of HDBB was elucidated by comparison with gene expression data of typical PPAR alpha agonist, i.e. clofibrate, WY-14643, gemfibrozil, and fenofibrate, from TG GATEs database. Moreover, we analyzed for PPAR alpha mRNA expression in the liver of developing male and female rats. PPAR alpha mRNA expression level was higher in males than in females on postnatal days (PNDs) 28 and 35, whereas no sex-related difference was found on PNDs 7 and 22. These results suggest that HDBB exerts its hepatotoxicity through the PPAR alpha signal pathway and the sex-related difference in PPAR alpha expression may contribute to the sex-related difference in susceptibility to hepatotoxicity.

Web of Science

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

【はじめに】1,4-ジクロロブタン（CAS No. 110-56-5）は医薬品・農薬・香料の原料や溶媒として使用される化審法上の既存化学物質であり、ヒト健康影響のスクリーニング評価を行うためにラット28日間反復投与試験（OECD TG 407）、ラット簡易生殖発生毒性試験（OECD TG 421）を実施した。【方法】雌雄のCrl:CD(SD)ラット（6-12匹/性/群）に1,4-ジクロロブタンを0、12、60、300 mg/kg/day（溶媒：コーン油）の用量で28 日間強制経口投与し、対照群及び高用量群の半数の動物には14 日間の回復期間を設けた。本試験ではNOAELが得られなかったため、続いて実施した簡易生殖発生毒性試験では用量設定を0、2.4、12、60 mg/kg/dayとし、交配前14日から雌は分娩後3日までの40-50日間、雄は剖検までの42日間強制経口投与した（12匹/性/群）。【結果】28日間反復投与試験において、雌雄ともに死亡例はなく、体重、摂餌量への影響は認められなかった。肝臓では、雄の300 mg/kg/day、雌の60 mg/kg/day以上で臓器重量が用量依存的に増加し、雄の60及び雌の12 mg/kg/day以上で軽微～中等度の門脈周囲性肝細胞腫大がほぼ全例に認められ、重篤度が用量依存的であった。雌雄の300 mg/kg/dayでは血中γ-GTPが上昇した。腎臓では、雌雄の300 mg/kg/dayで臓器重量の増加、全例に軽微な近位尿細管腫大、血中尿素窒素及び無機リンの上昇が認められた。膵臓では、雄の60及び雌の12 mg/kg/day以上で軽微～軽度のチモーゲン顆粒減少がほぼ全例に認められ、重篤度が用量依存的であったが、より高用量で実施した予備試験では影響が認められなかった。全ての影響について回復性が認められた。簡易生殖毒性試験では、分娩率の低下傾向がみられたが統計学的有意差はなかった。60 mg/kg/dayでは雄の肝重量増加が認められた。【考察】肝臓への影響は再現性があり、本物質の標的臓器と考えられた。300 mg/kg/dayでみられた腎臓での変化も本物質による影響と考えられた。2試験を総合的に評価した結果、本物質のNOAELは2.4 mg/kg/dayであった。一般毒性が生じない用量で生殖発生毒性は認められなかった。

DOI： 10.14869/toxpt.43.1.0_P-204

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

農薬の登録申請においては、毒性に関する試験成績として複数の動物種を用いた様々な毒性試験が要求されている。それらの試験成績は、農薬がその目的に応じて有効かつ安全に使用されるための基準を設定するために使用される。今日、要求されている試験や動物種は、ヒト健康影響を未然に防止するために必要と考えられる評価項目を可能な限り網羅することを念頭に経験的に決められてきたものであるが、実際の評価においては、NOAEL等の評価値算出に用いられる試験はそれらの一部であり、全ての農薬について要求される全ての試験が常に必要であるわけではない。近年、特にイヌ長期（1年間）試験やマウス発がん性試験の必要性について議論となっており、特にイヌ長期試験については欧米の評価機関では提出が必須とはされていない。農薬の安全性評価においては医薬品等と異なりヒト臨床データを用いることが困難である。そのため、動物試験のみの結果から安全性を担保する必要があり、最も感受性の高い動物種や発現する毒性が予め予測出来ない状況において、むやみに試験を削減することにより、ヒト健康被害が起きては本末転倒である。しかし、過去数十年の安全性評価により蓄積されてきた知見をもとに、評価の目的のため必要となる試験選択について科学的な見地から再検討を行う時期に来ているのではないだろうか。本発表では、食品安全委員会より公開されている農薬評価書をもとに、イヌ長期毒性試験もしくはマウス発がん性試験を根拠として1日摂取許容量(ADI)設定が行われた農薬について、それらの試験結果が得られなかった場合のADI設定への影響についての解析結果やそれらの農薬についてのJMPR等海外評価機関における評価状況をもとに、それらの試験の必要性や省略の可能性について議論を行う。

DOI： 10.14869/toxpt.43.1.0_S7-2

CiNii Article

researchmap

記述言語：英語   出版者・発行元：一般社団法人 日本毒性学会  

Perfluoroalkyl carboxylic acids (PFCAs) are global environmental contaminants that are the cause of concern due to their possible effects on wildlife and human health. Since few studies have investigated the toxicity of long-chain PFCAs, we have performed combined repeated dose toxicity studies with the reproduction/developmental toxicity screening tests. We previously examined perfluoroundecanoic acid (C11), perfluorododecanoic acid (C12), and perfluorooctadecanoic acid (C18). We herein reported our results for perfluorotetradecanoic acid (PFTeDA; C14) and perfluorohexadecanoic acid (PFHxDA: C16). Male and female rats were administered PFTeDA at 1, 3 or 10 mg/kg/day or PFHxDA at 4, 20 or 100 mg/kg/day by gavage, and each female was then mated with a male in the same dose group after 14 days. Males were dosed for a total of 42 days and females were dosed throughout the gestation period until day 5 after parturition. PFTeDA and PFHxDA caused hepatocyte hypertrophy and/or fatty changes in the liver at the middle and high doses. PFTeDA also induced follicular cell hypertrophy in the thyroid at the middle and high doses. The only reproductive/developmental effect observed was an inhibited postnatal body weight gain in pups in the 10 mg/kg/day PFTeDA group. Based on these results, the NOAELs for the repeated dose and reproductive/developmental toxicity were concluded to be 1 and 3 mg/kg/day for PFTeDA and 4 and 100 mg/kg/day for PFHxDA, respectively. Our current and previous results indicate that the toxicity of PFCAs decreases with increases in the carbon chain length from 12 to 18.

DOI： 10.2131/fts.2.177

CiNii Article

researchmap

その他リンク： http://search.jamas.or.jp/link/ui/2016381693

記述言語：英語   出版者・発行元：一般社団法人 日本毒性学会  

To obtain information on the possible repeated-dose oral toxicity of β-bromostyrene and its reversibility, Crl: CD (SD) rats were administered β-bromostyrene through gavage at 0, 30, 125, and 500 mg/kg/day once for 28 days, followed by a 14-day recovery period. In the 500 mg/kg group, decrease in spontaneous movement was observed in all males and females on the first dosing day, and one female rat died on Day 3. There were no significant changes in body weight or food consumption. An increase in urine volume and decrease in urine osmolality were observed in males receiving 125 mg/kg and above, and an increase in urine volume was observed in females receiving 500 mg/kg. On blood biochemical examination, increases in total cholesterol, phospholipids, triglycerides, total protein, albumin, inorganic phosphorus, and/or chlorine were observed in the 125 and/or 500 mg/kg groups. Histopathologically, eosinophilic bodies of tubular cells and/or renal tubular degeneration were observed in the kidneys of males in the 125 and 500 mg/kg groups. In the thyroid, hypertrophy of follicular cells was observed in females receiving 125 mg/kg and above and males receiving 500 mg/kg. Furthermore, centrilobular hepatocellular hypertrophy was observed in both sexes receiving 500 mg/kg. These changes observed at the end of the dosing period disappeared or were reduced after the recovery period. Based on these results, the no-observed-adverse-effect-level of β-bromostyrene was judged to be 30 mg/kg/day for both sexes.

DOI： 10.2131/fts.2.191

CiNii Article

researchmap

その他リンク： http://search.jamas.or.jp/link/ui/2016381694

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

Recent studies have shown. that epigenetic alterations correlate with carcinogenesis in various tissues. Identification of these alterations might help characterize the early stages of carcinogenesis. We comprehensively analyzed DNA methylation and gene expression in livers obtained from rats exposed to nitrosodiethylamine (DEN) followed by a promoter of hepatic carcinogenesis, phenobarbital (PB). The combination of DEN and PB induced marked increases in number and area of glutathione S-transferase-placental form (GST-P)-positive foci in the liver. In the liver of rats that received 30 mg/kg of DEN, pathway analysis revealed alterations of common genes in terms of gene expression and DNA methylation, and that these alterations were related to immune responses. Hierarchical clustering analysis of the expression of common genes from public data obtained through the Toxicogenomics Project-Genomics Assisted Toxicity Evaluation system (TG-GATEs) showed that carcinogenic compounds clustered together. MBD-seq and GeneChip analysis indicated that major histocompatibility complex class Ib gene RT1-CE5, which has an important role in antigen presentation, was hypomethylated around the promoter region and specifically induced in the livers of DEN-treated rats. Further, immunohistochemical analysis indicated that the co-localization of GST-P and protein homologous to RT1-CE5 was present at the foci of some regions. These results suggest that common genes were altered in terms of both DNA methylation and expression in livers, with preneoplastic foci indicating carcinogenic potential, and that immune responses are involved in early carcinogenesis. In conclusion, the present study identified a specific profile of DNA methylation and gene expression in livers with preneoplastic foci. Early epigenetic perturbations of immune responses might correlate with the early stages of hepatocarcinogenesis.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non-genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that repeated doses of non-genotoxic carcinogens might have initiating potential. Here, we conducted a two-stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB). The duration of initial treatment was determined based on positive results from our prediction model. Combined treatment of 3 or 30 mg/kg of genotoxic DEN and PB induced marked increases in altered hepatocellular foci and a DEN dose-dependent increase in the number and area of glutathione S-transferase-placental form (GST-P)-positive foci. A low number of altered hepatocellular foci were also observed in rats treated with TAA at a dose of 45 mg/kg. MP at a dose of 100 mg/kg induced a very low number of foci, but APAP did not. Hierarchical clustering analysis using gene expression data revealed that 2-week treatment with TAA at a dose of 30 mg/kg and MP at 45 mg/kg induced specific expression of DNA damage-related genes, similar to 1-week treatment with DEN at a dose of 30 mg/kg. These results suggest that TAA and MP induce DNA damage, which partially supports our hypothesis. Although this study does not indicate whether tumor growth in response to these compounds can be assessed in this model, our results suggest that cumulative treatment with non-genotoxic TAA might have initiating potential in the liver.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

Perfluoroalkyl acids (PFAAs) are environmental contaminants that have received attention because of their possible effects on wildlife and human health. In order to obtain initial risk information on the toxicity of perfluoroundecanoic acid (PFUA), we conducted a combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (OECD test guideline 422). PFUA was administered by gavage to rats at 0 (vehicle: corn oil), 0.1, 0.3 or 1.0 mg/kg/day. At 1.0 mg/kg/day, body weight gain was inhibited in both sexes, and there was a decrease in fibrinogen in both sexes and shortening of the activated partial thromboplastin time in males. An increase in blood urea nitrogen and a decrease in total protein in both sexes and increases in alkaline phosphatase and alanine transaminase and a decrease in albumin in males were observed at 1.0 mg/kg/day. Liver weight was increased in males at 0.3 mg/kg/day and above and in females at 1.0 mg/kg/day, and this change was observed after a recovery period. In both sexes, centrilobular hypertrophy of hepatocytes was observed at 0.3 mg/kg/day and above and focal necrosis was observed at 1.0 mg/kg/day. In reproductive/developmental toxicity, body weight of pups at birth was lowered and body weight gain at 4 days after birth was inhibited at 1.0 mg/kg/day, while no dose-related changes were found in the other parameters. Based on these findings, the no observed adverse effect levels (NOAELs) for the repeated dose and reproductive/developmental toxicity were considered to be 0.1 mg/kg/day and 0.3 mg/kg/day, respectively.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

Hypothyroidism induced by xenobiotic treatment was analyzed for possible underlying mechanism(s) on the basis of different responses of the thyroid gland and the liver, using a newly-created database of repeated-dose toxicity of 500 chemicals. Two mechanisms are proposed: direct inhibition of thyroid hormone biosynthesis in the thyroid gland, and stimulated degradation of thyroid hormone by induction of hepatic drug-metabolizing enzymes. In the database there were 10 chemicals inducing hypertrophy/hyperplasia of follicular cells in the thyroid gland and having data on thyroid glands. On the basis of the chemical structure and information available in the literature, we judged three chemicals to be typical thioamide derivatives that act directly on the thyroid gland, and the others as non-thioamide derivatives that were unlikely to have any direct action on the thyroid gland. All these chemicals were classified into two groups using the ratios of relative weight increase rate of thyroid gland versus that of the liver. These values were at least 1.7, but 3.2 or more in the most of the cases for thioamide derivatives, and 1.2 or less for non-thioamide derivatives. This background analysis suggests the feasibility of parameter-supported speculation on the possible underlying mechanism when new repeated-dose toxicity data on hypothyroidism becomes available.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

In order to develop guidelines for setting acute reference doses (ARfDs) for pesticides in Japan, we conducted simulations of ARfD settings based on evaluation reports for 201 pesticides assessed by the Food Safety Commission (FSC) in Japan over the last 8 years. Our conceptual principles were based on the concepts written by Solecki et al. (2005) and were adapted for toxicological data required in Japan. Through this process, we were able to set the ARfDs for over 90% of the 201 pesticides tested. The studies that provided the rationale for ARfD setting were primarily reproductive and developmental toxicity studies, acute neurotoxicity studies, and pharmacology studies. For approximately 30% of the pesticides simulated in the present study, it was not necessary to establish ARfDs. Some of the simulated ARfDs resulting from their endpoints may be conservative estimates, because the evaluation reports were written for acceptable daily intake settings. Thus, it was sometimes difficult to distinguish acute toxic alerts from repeated toxicities. We were unable to set an ARfD for 14 pesticides because of insufficient data on acute toxicities. This could be improved by more complete recordkeeping. Furthermore, we categorized the 201 pesticides by mechanism of action or chemical structure. Our simulation indicates that the conceptual framework presented here can be used as a basis for the development of guidelines on ARfD settings for pesticides in Japan.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

The concern over endocrine disruptors prompted international establishment of a strategic framework for the identification of the estrogenic compounds. OECD has launched the Conceptual Framework tool box containing various screening and testing methods including the uterotrophic assay. The (anti)estrogenicity of 36 chemicals suspected to be estrogen-receptor interactive by in silico and/or in vitro screening in the Extended Scheme for Endocrine Disruptor Screening and Testing of the Ministry of Health, Labour and Welfare, Japan, were monitored by the uterotrophic assay using C57BL/6J ovariectomized adult female mice after a 7-day exposure by oral gavage (po) and subcutaneous injection (sc). Ethynyl estradiol was used as reference for agonist and antagonist detection. In addition, Bisphenol A (sc) and Genistein (po) were tested for the comparison to rat assays. Among the 36, 2-[Bis(4-hydroxyphenyl)methyl]benzylalcohol, 2,2',4,4'-Tetrahydroxybenzophenone, 2,4-Dihydroxybenzophenone, 3,3',5-Triiodothyroacetic acid, New fuchsin and alpha-Naphtholbenzein, showed both estrogenic agonistic and antagonistic activities; first two showed U-shaped dose-response in antagonistic studies. N,N-Diphenyl-p-phenylenediamine, 2,2'-Dihydroxy-4,4'-dimethoxybenzophenone, n-Butyl 4-hydroxybenzoate, and Reserpine were agonistic by sc. Benzo at pyrene, Benz [a] anthracene, Dibenz [a,h] anthracene, 2-(2H-Benzotriazol-2-yl)-4,6-di(t-pentyl)phenol. Rosemarinic acid, meta-Thymol, 6-Gingerol, Colchicine, Malachite green base, Fenbuconazole, and Lead acetate were antagonistic. The rest, i.e. n-Heptyl 4-hydroxybenzoate, Tetrazolium violet, Pravastatin sodium salt. Physostigmine, salicylate (1:1), Nordihydroguaiaretic acid, o-Cresolphthalein, 1,3-Dinitrobenzene, C.I. Pigment orange, Tetrabromobisphenol-A, 2-Hydroxy-4-methoxybenzophenone, Ethylparaben, Propyl p-hydroxybenzoate, Kaempferol, 2-(2-Benzotriazolyl)-p-cresol and Phenolphthalein were negative for both effects. Taking together with in silico/ in vitro screening, the result suggested that the ovariectomized mouse uterotrophic bioassay has sufficient performance comparable to rat for the screening of (anti)estrogenicity of various chemicals.

DOI： 10.2131/jts.37.879

Web of Science

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

An important technology used in toxicogenomic drug discovery research is the microarray, which enables researchers to simultaneously analyze the expression of a large number of genes. To build a database and data analysis system for use in assessing the safety of drugs and drug candidates, in 2002 we conducted a 5-year collaborative study in the Toxicogenomics Project (TGP1) in Japan. Experimental data generated by such studies must be validated by different laboratories for robust and accurate analysis. For this purpose, we conducted intra- and inter-laboratory validation studies with participating companies in the second collaborative study in the Toxicogenomics Project (TGP2). Gene expression in the liver of rats treated with acetaminophen (APAP) was independently examined by the participating companies using Affymetrix GeneChip microarrays. The intra- and inter-laboratory reproducibility of the data was evaluated using hierarchical clustering analysis. The toxicogenomics results were highly reproducible, indicating that the gene expression data generated in our TGP1 project is reliable and compatible with the data generated by the participating laboratories.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

Three female Crl:CD(SD) rats/group were dosed with single wall carbon nanotube (SWCNT) or multi wall carbon nanotube (MWCNT) four times by gavage at a total of 50 mg/kg bw or 200 mg/kg bw (four equally divided doses at one-hour intervals). Acute oral doses of SWCNT and MWCNT caused neither death nor toxicological effects, and thus the oral LD50 values for SWCNT and MWCNT were considered to be greater than 50 mg/kg bw and 200 mg/kg bw, in rats respectively. Five or ten Crl:CD(SD) rats/sex were dosed with SWCNT once daily by gavage at a dose of 0 (control), 0.125, 1.25 or 12.5 mg/kg bw/day for 28 days with a 14-day recovery period (0 and 12.5 mg/kg bw/day groups). Six or twelve Crl:CD(SD) rats/sex were dosed with MWCNT once daily by gavage at a dose of 0 (control), 0.5, 5.0 or 50 mg/kg bw/day for 28 days with a 14-day recovery period (0 and 50 mg/kg bw/day groups). Based on no toxicological effects, the no observed adverse effect levels (NOAELs) of repeated dose toxicity of SWCNT and MWCNT were considered to be 12.5 mg/kg bw/day and 50 mg/kg bw/day (the highest dose tested), respectively. It was suggested that SWCNT and MWCNT dosed by gavage reached the gastro-intestinal tract as agglomerates and were mostly excreted via feces.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD  

Most exposure levels of flavor in food are considered to be extremely low. If at all, genotoxic properties should be taken into account in safety evaluations. We have recently established a (quantitative) structure-activity relationship, (Q)SAR, combination system, which is composed of three individual models of mutagenicity prediction for industrial chemicals. A decision on mutagenicity is defined as the combination of predictive results from the three models. To validate the utility of our (Q)SAR system for flavor evaluation, we assessed 367 flavor chemicals that had been evaluated mainly by JECFA and for which Ames test results were available. When two or more models gave a positive evaluation, the sensitivity was low (19.4%). In contrast, when one or more models gave a positive evaluation, the sensitivity increased to 47.2%. The contribution of this increased sensitivity was mainly due to the result of the prediction by Derek for Windows, which is a knowledge-based model. Structural analysis of false negatives indicated some common sub-structures. The approach of improving sub-structural alerts could effectively contribute to increasing the predictability of the mutagenicity of flavors, because many flavors possess categorically similar functional sub-structures or are composed of a series of derivatives. (C) 2012 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.fct.2012.02.009

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

To obtain initial information on the possible repeated-dose oral toxicity of fullerene C60, Crl:CD(SD) rats were administered fullerene C60 by gavage once daily at 0 (vehicle: corn oil), 1, 10, 100, or 1,000 mg/kg/day for 29 days, followed by a 14-day recovery period. No deaths occurred in any groups, and there were no changes from controls in detailed clinical observations, body weights, and food consumption in any treatment groups. Moreover, no treatment-related histopathological changes were found in any organs examined at the end of the administration period and at the end of the recovery period. Blackish feces and black contents of the stomach and large intestine were observed in males and females at 1,000 mg/kg/day in the treatment group. There were no changes from controls in the liver and spleen weights at the end of the administration period, but those weights in males in the 1,000 mg/kg/day group increased at the end of the recovery period. Using liquid chromatography-tandem mass spectrometry, fullerene C60 were not detected in the liver, spleen or kidney at the end of the administration period and also at the end of the recovery period. In conclusion, the present study revealed no toxicological effects of fullerene C60; however, the slight increases in liver and spleen weights after the 14-day recovery period may be because of the influence of fullerene C60 oral administration. In the future, it will be necessary to conduct a long-term examination because the effects of fullerene C60 cannot be ruled out.

Web of Science

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

Male and female rats were given perfluorooctadecanoic acid (PFOdA) by gavage at 40, 200 or 1,000 mg/kg/day, and each female was mated with a male in the same dose group after 14-day administration. Males were dosed for 42 days and females were dosed throughout the gestation period until day 5 of lactation. One female given 1,000 mg/kg/day was euthanized on day 18 of gestation due to a moribund condition; however, no other treatment-related clinical signs of toxicity were observed. Body weights fell at 1,000 mg/kg/day from day 28 through the administration period in males and throughout gestation and lactation in females. Red blood cell count, hemoglobin level and hematocrit were decreased at 200 and 1,000 mg/kg/day in males and activated partial thromboplastin time was prolonged at 1,000 mg/kg/day in females. Histopathological examination revealed hepatic changes, such as centrilobular hypertrophy and necrosis, in males given 200 and 1,000 mg/kg/day and in females given 1,000 mg/kg/day. Pancreatic zymogen granule was decreased in both sexes at 1,000 mg/kg/day. As for reproductive and developmental toxicity, there were decreases in the number of corpora lutea, implantation, total number of pups born and the number of live pups on postnatal days 0 and 4 at 1,000 mg/kg/day. At this dose, birth weights of pups were decreased and postnatal body weight gain was inhibited. Based on these findings, the NOAEL of PFOdA was considered to be 40 mg/kg/day for repeated dose toxicity and 200 mg/kg/day for reproductive/developmental toxicity.

DOI： 10.2131/jts.37.63

Web of Science

Scopus

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

【背景・目的】トキシコゲノミクス・インフォマティクスプロジェクト（TGP2）において，ラット肝臓の網羅的遺伝子発現データに基づく遺伝毒性肝発がん物質の判別モデルを構築した。その有用性検証の一環として，我々は2段階肝発がんモデルラットを作製し，種々の検討を実施している。本検討では発がんに至る初期の段階で生じるエピジェネティックな変化を捉える目的で，二段階肝発がんモデルラットの肝において次世代シーケンサーを用いた網羅的DNAメチレーション解析を行い，前がん病変形成過程においてメチル化状態が変動する領域を探索した。【方法】ラット（Crl:CD (SD)IGS；6週齢）にDiethyl nitrosamine（DEN），Thioacetamide（TAA），Methapyrilene（MP），Acetaminophen（APAP）をそれぞれ2週間反復投与し，2週間休薬後にPhenobarbital（PB）飲水投与を開始した。PB投与1週間の時点で肝部分切除を行い，6週間後に解剖を行った。肝切除時および解剖時に採材した肝臓サンプルについてゲノムDNAを採取し，超音波による断片化後，MBD2タンパクによるメチル化DNAの分画を行った。このメチル化DNAについて，Life technologies社のSOLiD4を使用してシーケンス及びマッピング解析を行った。【結果】単一のCpG，CpGアイランド，エクソン，イントロン，及びプロモーター領域のメチル化状態の変化を調べた結果，各化合物を処置したラットの剖検時の肝において，メチル化状態に変化が認められる領域が多数見つかった。肝切除時のDNAにおいても変動領域が認められたことから，DNAメチル化は変動の大きさに違いはあるものの，週齢や化合物処置により変動しうるものであることが示唆された。また二段階発がん試験において陽性と判定されたDEN投与ラット肝DNAで特異的な変動領域が存在し，これらの領域と発がんに何らかの関連がある可能性が考えられた。今後は本解析によって見出された変化と発がんメカニズムの関連について，より詳細な検討を実施していく予定である。

DOI： 10.14869/toxpt.39.1.0.P-240.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

【背景および目的】トキシコゲノミクス・インフォマティクスプロジェクト（TGP2）において構築された遺伝子/毒性データベースであるTG-GATEsを用いて，ラット肝臓のマイクロアレイデータに基づく遺伝毒性肝発がん物質の判別モデルを構築した．その有用性検証の一環として，我々は2段階肝発がんモデルラットを作製し，種々の検討を実施した．本検討では，2段階肝発がんモデルラットの肝及び血漿における糖鎖プロファイルの変動について，レクチンアレイを用いて解析を行った．【方法】ラット（Crl:CD (SD)IGS；6週齢）にDiethyl nitrosamine（DEN），Thioacetamide（TAA），Methapyrilene，Ethionamide及びAcetaminophenを2週間反復投与し，2週間休薬後にPhenobarbital（PB）飲水投与を開始した．PB投与1週間の時点で肝部分切除を行い，6週間後に解剖を行った．解剖時における糖鎖プロファイルの変化についてレクチンアレイを用いて解析し，前がん病変の発現との相関について検討した．【結果】肝においては，前がん病変が最も顕著に認められたDEN高用量群において，最多である18種類のレクチンに反応増加が認められ，DEN低用量群でも一部共通した変化が認められた．弱い前がん病変の認められていたTAA投与群においては，高用量よりも低用量の方で多くのレクチンで反応増加が認められていたが，その原因は不明であった．変動していたレクチンより糖鎖構造の変化について推定したところ，特徴的な糖の脱離，付加やO型糖鎖の増加，糖鎖構造の絶対数増加を示唆するような変化が捉えられ，一般的にがん細胞に認められる糖鎖の変化と一致していた．これらのことから，前がん病変段階でも既に糖鎖構造はがん細胞に特徴的な形態に遷移し始めていることが示唆された．血漿においては，DEN高用量では5種類のレクチンに反応減少が認められており，この変化をもとにバイオマーカーの可能性について検討している．

DOI： 10.14869/toxpt.39.1.0.P-237.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

我が国における農薬のヒト健康影響評価は、慢性曝露を対象としており、ヒトが一生涯にわたり毎日摂取しても健康に影響しない基準値として一日許容摂取量（Acceptable Daily Intake: ADI）が設定されている。近年、海外では農薬などを短期間に大量摂取したために中毒となる症例が発生した事例等を発端として、慢性曝露のみでなく急性曝露影響を評価し、その指標として急性参照用量(Acute Reference Dose: ARfD)を設定する取り組みが始められている。WHO/FAO合同農薬残留専門家会議（JMPR）では、1999年より急性曝露評価を開始するとともに、2002年には、ARfDを、「24時間以内に摂取してもヒト健康に影響を及ぼさない量」と定義している。我が国においては、過去に農薬混入等の中毒事例に関連した参考値としてARfDが設定された例を除いて急性曝露影響の評価は実施されていないが、ヒトが農薬等を事故的に短期間曝露した場合に起こりうる健康影響について評価を行い、ARfDを整備することは、食の安全のために重要である。しかしながら、実際のARfD設定においては、従来の安全性試験における急性毒性試験は致死のみをエンドポイントとしている、一方、その他の各種毒性試験は慢性影響の評価を目的としているため急性期影響の評価指標は限られており、さらに発現した毒性が急性影響であるという科学的根拠を示すための専門的知識が要求されることから不確定な要素が残されており、海外においても考え方がまだ十分に確立されていない。そこで我々は、公開されている農薬評価書等をもとに約200農薬についてARfDの設定を試みた。本講演では、急性曝露影響の必要性とともに我々の検討結果をもとに既存情報からのARfD設定の可能性と課題について概説する。

DOI： 10.14869/toxpt.39.1.0.S7-1.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

パーフルオロドデカン酸 (PFDdA)の毒性を明らかにするために、OECDテストガイドライン422に従って、反復投与毒性・生殖毒性併合試験を行った。雌雄のCrl:CD(SD)ラットに、0.1、0.5もしくは2.5 mg/kg bw/dayのPFDdAを毎日強制経口投与し、14日後から交配させた。雄動物は、交配期間を通して計42日間、雌動物は交配及び妊娠期間を通して、分娩後5日まで投与を続けた。その結果、2.5 mg/kg bw投与群では、雄では投与21日から投与終了時まで、雌では妊娠及び哺育期間を通して体重が低値を示した。血液生化学検査の結果、0.5 mg/kg bw以上の投与群で、総タンパク、アルブミン及びグルコースの低下、ALP、総ビリルビン及びBUNの増加などが認められた。0.5 mg/kg bw以上の投与群では、相対肝重量が高値を示し、病理組織学検査の結果、2.5 mg/kg bw投与群の肝臓に肝細胞肥大や壊死などが観察された。さらに、2.5 mg/kg bw投与群では、膵臓のチモーゲン顆粒の減少、骨髄の造血低下の他、脾臓、胸腺及び副腎の萎縮が認められた。生殖・発生への影響としては、2.5 mg/kg bw投与群では、12例中7例が妊娠後期に死亡もしくは瀕死状態となり、さらに、生存児を出産しなかった雌が4例みられた。交配させずに2.5 mg/kg bw/dayのPFDdAを42日間投与したサテライト群では、雌5例全例に性周期の異常が認められた。さらに、2.5 mg/kg bw投与群の雄では、生殖器官に様々な病理組織学的変化が観察されたが、交配率及び受胎能への影響は見られなかった。これらの結果から、PFDdAの反復投与毒性及び生殖発生毒性に関する無毒性量は、それぞれ0.1 mg/kg bw/day及び0.5 mg/kg bw/dayと結論された。

DOI： 10.14869/toxpt.39.1.0.P-126.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

【背景および目的】トキシコゲノミクス・インフォマティクスプロジェクト（TGP2）は，トキシコゲノミクスによる安全性バイオマーカーの探索を行い，医薬品開発の効率化を目指す産官共同研究である．本プロジェクトでは，ゲノミクスによるバイオマーカーの検討を進める一方，近年飛躍的に研究が進行しているマイクロRNA（miRNA）についてもバイオマーカーとしての有用性に注目し研究を行っている．本検討では，シスプラチン（CDDP）投与ラット腎障害モデルを作製し，尿及び腎についてmiRNAの発現変動解析を行い，各種生化学検査値，病理検査結果との比較を行った．その結果見出された尿中miRNAについて，バイオマーカーとしての有用性を検証した．【方法】ラット（Crl:CD (SD)IGS；8週齢）にCDDP（0, 1, 4 mg/kg）を静脈内投与し，24及び48時間後に体重，尿量及び摂水量を測定し，腎，尿及び血漿を採取した．血液及び尿生化学検査を行い，尿中及び腎（48時間のみ）におけるmiRNAの測定及び腎病理組織学的検査を行った．【結果】CDDPのいずれの投与群においても，体重，尿量，摂水量，尿クレアチニンなどの低下が24，48時間ともに認められた．また，腎病理組織学的検査では，CDDPの投与後24時間から，4 mg/kg投与群の全例（N=7）において核クロマチン変性（近位尿細管直部）が認められ，投与後48時間には尿細管壊死も認められた．尿におけるmiRNAアレイ解析の結果，4 mg/kg投与群において投与後24時間では約20種類，投与後48時間では50種類以上のmiRNAの有意な変動が認められ，腎障害時にはより多くのmiRNAが尿中に検出されることが示唆された．一方，腎におけるmiRNAはほとんど変動を示さなかった．投与後48時間において尿中で顕著に増加したmiRNAについてPCRを実施し，miRNAアレイと比較した結果も報告する．

DOI： 10.14869/toxpt.39.1.0.P-236.0

CiNii Article

researchmap

その他リンク： http://search.jamas.or.jp/link/ui/2013205085

記述言語：日本語   出版者・発行元：日本毒性学会  

医薬品や化学物質の発がんリスクは，長期がん原性試験において判定されるが，その代替法として，簡便かつ短期の発がん性リスク評価系の確立が望まれる．我々は，トキシコゲノミクス・インフォマティクスプロジェクトの産官学共同研究を通じて，化合物の遺伝毒性，非遺伝毒性肝発がん作用を最長28日間のラット反復投与試験で高精度に予測するトキシコゲノミクス判別モデルを構築した．今回，5種の化学物質 [肝発がん物質：nitrosodiethylamine (DEN)，thioacetamide (TAA)，methapyrilene，非発がん物質：acetaminophen，ethionamide] の肝イニシエーション作用の有無を，phenobarbitalをプロモーターとしたラット肝二段階発がん試験法を用いて検討した．イニシエーション活性の有無は，肝臓の病理組織学的検査，GST-P免疫組織化学染色による陽性細胞巣の計測により判定した．その結果，既知の遺伝毒性肝発がん物質であるDENに加え，文献的に非遺伝毒性肝発がん物質として報告されているTAAにイニシエーション作用が認められた．本試験成績は，トキシコゲノミクス判別モデルにより得られた予測結果と一致し，我々の構築した判別モデルの予測結果の妥当性の裏づけとなるものである．さらに我々は，クロスオミックスアプローチによる発がんメカニズムの解明や新規バイオマーカー探索を目的として，二段階発がんモデルにおいて採取したラットの肝臓及び血漿におけるマイクロRNA発現解析，次世代シーケンサーを用いた肝臓の網羅的DNAメチレーション解析，レクチンアレイを用いた肝臓の糖鎖プロファイル解析を実施した．本発表では，トキシコゲノミクス及び病理組織学的アプローチによる肝発がん物質のイニシエーション活性の検索を中心に，一連の研究成果を総括する．

DOI： 10.14869/toxpt.39.1.0.P-238.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

【背景】フタル酸エステル類はアルキル基の違いによって活性化するPPAR亜型とその親和性や毒性標的は異なる。我々は昨年度の本学会にて、フタル酸ジへプチル(DHP)はラットへの90日間混餌投与により高用量域でのみPPARα非依存的にGST-P陽性肝前がん病変を形成することを明らかにした。本研究では作用機序や作用強度の異なるフタル酸エステルの併用投与による肝臓及び雄性生殖器に与える影響を検討するために、6週齢の雄性F344ラットにフタル酸ビス(2-エチルヘキシル) (DEHP; 12,000 ppm)、フタル酸ジブチル (DBP; 12,000 ppm)、DHP (10,000 ppm)を単独あるいはDEHPとDBP、DEHPとDHPの組み合わせで90日間混餌投与を行なった。【結果】肝臓ではDEHP単独群でみられた好酸性肝細胞肥大がDBPとの併用で増強し、DHP単独群でみられた肝細胞の腫大・空胞変性はDEHPとの併用で消失した。α2-macroglobulinの免疫染色では、DHP単独群のみでGST-P同様に陽性巣を形成したが、これらはいずれもDEHPとの併用で消失した。また、DHP単独群のみでPCNA陽性細胞率が増加した。精巣では各単独群では有意な変化を示さず、両併用投与群で精細胞の脱落を主としたびまん性の精細管萎縮を示した。肝臓におけるreal-time RT-PCRではAcox, Ehhadh及びCyp4a1などPPARα依存性の因子の発現増加はDEHP及びDBP単独群でみられ、これらの併用で増強した。また、活性酸素種産生酵素Nox2はDHP単独群で発現増加したが、DEHPとの併用で抑制され、DHP単独群でみられたSod1, Sod2及びCatなどの酸化還元酵素の発現減少はDEHPとの併用で回復した。さらに、DNA酸化傷害指標の8-OHdGが全投与群で対照群より増加したが、併用による相加作用はみられなかった。【考察】肝臓ではDEHPによるPPARα活性に対するDBPの増強作用と、DHPによる酸化ストレス誘発及び肝細胞の増殖作用に対するDEHPの拮抗作用が推察され、精細管萎縮については併用による相加または増強作用が推定された。

DOI： 10.14869/toxpt.39.1.0.P-166.0

CiNii Article

researchmap

その他リンク： http://search.jamas.or.jp/link/ui/2013205015

記述言語：日本語   出版者・発行元：日本毒性学会  

我々は大量の網羅的遺伝子発現データを含む大規模データベースシステム"TG-GATEs"を構築し，それを用いて各種毒性を検出するバイオマーカーの抽出を行ってきた．TG-GATEs には150以上の化合物をin vivo投与したラットの肝および腎，in vitroで曝露したラットとヒトの初代培養肝細胞の遺伝子発現データが含まれる．以前我々はラット肝臓および初代培養肝細胞で利用できるPPARαアゴニストマーカーについて報告しており(J. Toxicol. Sci., 31, 471-490, 2006)，その改良および検証について第85回日本薬理学会年会で報告したが，さらに今回ヒト初代培養肝細胞に適用できる判別モデルの構築および検証を行った．PPARα活性化薬物で共通に変動した遺伝子を抽出し，サポートベクターマシン(SVM)を用いて判別モデルを構築した．TG-GATEsのデータでは，典型的なPPARα活性化薬であるフィブラート系薬物の他，ベンジオダロンや多くのNSAIDsなどが陽性と判別された．この結果はラット初代培養肝細胞の場合と一致していた．またPPARαとコアクチベーターとの結合アッセイを用いてアゴニスト活性を確認した．外部の公共データベース上のデータについても判別を行ったところ，陽性化合物のWY-14643と陰性化合物のリファンピシンはそれぞれ正しく判別された．判別モデルに用いた遺伝子は脂質代謝に関連しPPARとの関連が知られているものが多かったが，ラットの判別モデルに用いた遺伝子と共通のものはなかった．発現変動のみられた遺伝子は全体としてラットより大幅に少なかったが，それらはラットでも変動がみられた．今回，PPARαアゴニスト検出に役立つ，信頼性・頑健性の高い判別モデルが構築できた．今後ラットモデルとの比較などさらに解析を進め，種差の原因解明などにもつなげたい．

DOI： 10.14869/toxpt.39.1.0.P-233.0

CiNii Article

researchmap

その他リンク： http://search.jamas.or.jp/link/ui/2013205082

記述言語：日本語   出版者・発行元：日本毒性学会  

【背景・目的】小胞体はタンパク質の合成・折り畳みを司る重要な細胞小器官である．小胞体において変性タンパク質が過剰に蓄積するストレス状態が続くと，正常な機能が妨げられ，最終的には細胞死が誘導される．肝臓では多数のシトクロムP450が小胞体に局在し薬物代謝を行っていることから，小胞体ストレスを評価するマーカーは肝障害の機序解明に有用であると考えられる．本研究ではトキシコゲノミクスプロジェクトにおいて構築されたデータベース（TG-GATEs）を用いて，ヒトおよびラット肝細胞で肝臓の小胞体ストレスを予測・評価するマーカーの探索を行い，その有用性を検討した．【手法】Affymetrix社製のGeneChipを用いてヒトおよびラット肝細胞の網羅的遺伝子発現データを取得し発現差異解析を行った．正例は「小胞体ストレスを誘発することが知られているNSAIDs 4化合物」，負例は「ラットin vivoにて小胞体ストレス応答遺伝子の変動が見られない8化合物」と設定し，いずれも24時間曝露のデータを使用した．既知の小胞体ストレス応答遺伝子群から(i) 正負例間での倍率変化が1.5倍より大きい，もしくは2/3倍より小さい(ii) Mann-WhitneyのU-testにてP値<0.01という2つの条件を設定しマーカー候補となる遺伝子を絞り込んだ．そして，SVMにより予測モデルを構築し，5-fold Cross ValidationおよびTG-GATEs収載の他の化合物への予測を実行し妥当性の検証を行った．【結果】発現差異解析の結果，ATF4, SERP1の2遺伝子がマーカー候補として絞り込まれた．この2遺伝子を用いた5-fold Cross Validationの検証結果は良好であり，小胞体ストレス性化合物であるCyclosporine Aを陽性と判定するなど他の化合物への予測結果も妥当なものであった．【結論】本研究を通じて，ヒトおよびラット肝細胞で肝臓の小胞体ストレスを予測・評価するマーカーとして，ATF4, SERP1の2遺伝子が有用であることを見出した．

DOI： 10.14869/toxpt.39.1.0.P-230.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

【背景・目的】我々は2段階肝発がんモデルラットを作製し，種々の検討を実施している。本検討では，2段階肝発がんモデルラットの肝及び血漿における網羅的マイクロRNA発現解析を行い，前がん病変形成過程におけるマイクロRNAの関与およびバイオマーカーとしての有用性について検討した。【方法】雄性ラット（Crl:CD (SD)IGS；6週齢）にDiethyl nitrosamine（DEN），Thioacetamide（TAA），Methapyrilene（MP），Ethionamide（ETN）及びAcetaminophen（APAP）を2週間反復投与し，2週間休薬後にPhenobarbital（PB）飲水投与を開始した．PB投与1週間の時点で肝部分切除を行い，6週間後に解剖を行った．血漿は2週間休薬後と解剖時，肝臓は肝部分切除時と解剖時に採材し検討に用いた。マイクロRNA発現データはマイクロアレイを用いてデータを取得した。【結果】肝臓における発現解析の結果，各薬物投与群において5から10種のマイクロRNAについて発現の増加および減少が認められた。前がん病変であるGST-P陽性肝細胞巣の有無による違いを調べた結果，GST-P陽性細胞巣が認められたDENおよびTAAにおいて，miR-34 familyであるmiR-34a, -34b, -34cの発現変化が認められた。miR-34 familyはDNA障害やp53シグナリングとの関与が報告されており，発がんメカニズムにおける重要な因子である事が推察された。血漿における発現解析では，各薬物投与群において発現変化を示すマイクロRNAは認められたが，GST-P陽性細胞巣の有無による違いは特に認められなかった。同組織で取得されたmRNA発現データとの統合解析を行い，メカニズム解析およびバイオマーカーとしての有用性について報告する。

DOI： 10.14869/toxpt.39.1.0.P-239.0

CiNii Article

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

To assess the repeated-dose toxicity of fullerene C60 by oral exposure, an OECD guideline test (TG 407) was conducted with administration of fullerene C60 at 0 (vehicle: corn oil), 1, 10, 100, or 1,000 mg/kg/day for 29 days in rats. No changes were observed in clinical observations, body weights, and food consumption in any treatment groups. Moreover, no treatment-related histopathological changes were found in any organs examined. Blackish feces and black contents of the stomach and large intestine were observed in males and females at 1,000 mg/kg/day in the treatment group. No significant changes in any organ weights were observed at the end of the administration period, but the only organ weights in liver and spleen in the 1,000 mg/kg/day group of male were increased at the end of the recovery period (14 days after the treatment period). The causal relationships between the possible absorption of fullerene C60 and those weight changes were suggested, but the pathological findings as indirect influences, such as swelling and congestion, were not also observed in the those organs. Using LC-MS/MS spectrometry analysis, fullerene C60 were not detected in the liver, spleen or kidney at the end of the administration period and also at the end of the recovery period. In conclusion, the present study revealed no toxicological effects of fullerene C60; however, with the prospective exposure by increased uses in future because of low toxic substance, more long-term exposure study is necessary to clarify the effects of fullerene C60 via oral exposure.

DOI： 10.14869/toxpt.39.2.0.AP-166.0

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

The present study was performed to develop a robust gene-based prediction model for early assessment of potential hepatocarcinogenicity of chemicals in rats by using our toxicogenomics database, TG-GATEs (Genomics-Assisted Toxicity Evaluation System developed by the Toxicogenomics Project in Japan). The positive training set consisted of high- or middle-dose groups that received 6 different non-genotoxic hepatocarcinogens during a 28-day period. The negative training set consisted of high- or middle-dose groups of 54 non-carcinogens. Support vector machine combined with wrapper-type gene selection algorithms was used for modeling. Consequently, our best classifier yielded prediction accuracies for hepatocarcinogenicity of 99% sensitivity and 97% specificity in the training data set, and false positive prediction was almost completely eliminated. Pathway analysis of feature genes revealed that the mitogen-activated protein kinase p38- and phosphatidylinositol-3-kinase-centered interactome and the v-myc myelocytomatosis viral oncogene homolog-centered interactome were the 2 most significant networks. The usefulness and robustness of our predictor were further confirmed in an independent validation data set obtained from the public database. Interestingly, similar positive predictions were obtained in several genotoxic hepatocarcinogens as well as non-genotoxic hepatocarcinogens. These results indicate that the expression profiles of our newly selected candidate biomarker genes might be common characteristics in the early stage of carcinogenesis for both genotoxic and non-genotoxic carcinogens in the rat liver. Our toxicogenomic model might be useful for the prospective screening of hepatocarcinogenicity of compounds and prioritization of compounds for carcinogenicity testing. (C) 2011 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.taap.2011.07.001

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD  

Aluminium ammonium sulfate (AAS) was tested for reproductive/developmental toxicity in a two-generation study. Male and female rats were continuously given AAS in drinking water at 0, 50, 500 or 5000 ppm. Water consumption was decreased in all AAS-treated groups, and the body weight of parental animals transiently decreased in the 5000 ppm group. In either generation, no compound-related changes were found in estrous cyclicity, sperm parameters, copulation, fertility and gestation index, number of implantations and live birth pups, sex ratios of pups or viability during the preweaning period. Male and female F1 pups in the 5000 ppm group showed a lower body weight on postnatal day 21, while there were no differences in the birth weight of F1 and F2 pups between the control and AAS-treated groups. Preweaning body weight gain in F2 males and females indicated a similar decreasing tendency at 5000 ppm. In F1 and F2 weanlings, the weight of the liver, spleen and thymus decreased at 5000 ppm, but no histopathological changes were found in these organs. In F1 females in the 5000 ppm group, vaginal opening was delayed slightly. There were no compound-related changes in male preputial separation or in other developmental landmarks. In behavioral tests conducted for F1 animals at 4-6 weeks of age, no compound-related changes were found in spontaneous locomotor activity and performance in a water-filled multiple T-maze. In conclusion, the NOAEL of AAS for two-generation reproductive/developmental toxicity was considered to be 500 ppm in rats. Considering the aluminium content in the basal diet, the total ingested dose of aluminium from drinking water and food in this 500 ppm group was calculated to be 5.35 mg Al/kg bw/day. (C) 2011 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.fct.2011.04.035

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD  

In a two-generation reproductive toxicity study, male and female rats were given aluminium sulfate (AS) in drinking water at 0, 120, 600 or 3000 ppm. AS reduced water consumption in all treatment groups, and body weight was transiently decreased in the 3000 ppm group. In the F1 and F2 pups, preweaning body weight gain was inhibited at 3000 ppm, and the liver and spleen weight was decreased at weaning. At this dose, vaginal opening was slightly delayed. There were no compound-related changes in other reproductive/developmental parameters, including developmental neurobehavioral endpoints. The data indicated that the NOAEL of AS in this two-generation study is 600 ppm for parental systemic toxicity and reproductive/developmental toxicity. The total ingested dose of aluminium from drinking water and food (standard rat diet, containing 25-29 ppm of aluminium) combined for this 600 ppm group was calculated to be 8.06 mg Al/kg bw/day. (c) 2010 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.reprotox.2010.11.004

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

We propose new uncertainty factors (UFs) and a new subdivision of default factors in chemical risk assessment using a probabilistic approach based on the latest applicable information. Rounded values of 150 for mice, 100 for hamsters and rats, and 40 for rabbits, monkeys and dogs for inter- and intra-species differences (UF(AH)) were derived from the probabilistic combination of two log-normal distributions. Further calculation of additional UFs when chronic data (UF(S)) or NOAEL (UF(L)) are lacking was conducted using available log-normal distribution information. The alternative UF(S) and UF(L) values of 4 are considered to be appropriate for both cases where data are lacking. The default contributions of inter-species difference (UF(A)) and intra-species difference (UF(H)) to the UF(AH) of 100 for hamsters and rats as an example are considered to be 25 and 4, respectively. The UF(A) of 25 was subdivided into 25(0.6) (i.e., 7.0) for pharmacokinetics (PK) (UF(A.PK)) and 25(0.4) (i.e., 3.6) for pharmacodynamics (PD) (UF(A.PD)), and the UF(H) of 4 was evenly subdivided into 4(0.5) (i.e., 2) (UF(H.PK) and UF(H.PD)), to account for chemical-specific difference data between humans and laboratory animals for PK and/or PD. These default UFs, which come from actual experimental data, may be more appropriate than previous default UFs to derive tolerable daily intake values. (C) 2010 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.yrtph.2010.06.006

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：WILEY-V C H VERLAG GMBH  

Biotechnology advances have provided novel methods for the risk assessment of chemicals. The application of microarray technologies to toxicology, known as toxicogenomics, is becoming an accepted approach for identifying chemicals with potential safety problems. Gene expression profiling is expected to identify the mechanisms that underlie the potential toxicity of chemicals. This technology has also been applied to identify biomarkers of toxicity to predict potential hazardous chemicals. Ultimately, toxicogenomics is expected to aid in risk assessment. The following discussion explores potential applications and features of the Japanese Toxicogenomics Project.

DOI： 10.1002/mnfr.200900169

Web of Science

Scopus

researchmap

記述言語：日本語   掲載種別：研究論文（学術雑誌）   出版者・発行元：128  

Tens of thousands of existing chemicals have been widely used for manufacture, agriculture, household and other purposes in worldwide. Only approximately 10% of chemicals have been assessed for human health hazard. The health hazard assessment of residual large number of chemicals for which little or no information of their toxicity is available is urgently needed for public health. However, the conduct of traditional toxicity tests which involves using animals for all of these chemicals would be economically impractical and ethically unacceptable. (Quantitative) Structure-Activity Relationships [(Q)SARs] are expected as method to have the potential to estimate hazards of chemicals from their structure, while reducing time, cost and animal testing currently needed. Therefore, our studies have been focused on evaluation of available (Q)SAR systems for estimating in vivo repeated toxicity on the liver. The results from our preliminary analysis showed the distribution for LogP of the chemicals which have potential to induce liver toxicity was bell-shape and indicating the possibility to estimate liver toxicity of chemicals from their physicochemical property. We have developed (Q)SAR models to in vivo liver toxicity using three commercially available systems (DEREK, ADMEWorks and MultiCASE) as well as combinatorial use of publically available chemoinformatic tools (CDK, MOSS and WEKA). Distinct data-sets of the 28-day repeated dose toxicity test of new and existing chemicals evaluated in Japan were used for model development and performance test. The results that concordances of commercial systems and public tools were almost same which below 70% may suggest currently attainable knowledge of in silico estimation of complex biological process, though it possible to obtain complementary and enhanced performance by combining predictions from different programs. In future, the combinatorial application of in silico and in vitro tests might provide more accurate information which support regulatory decisions. At the same time, an appropriate strategy to use (Q)SAR for of the efficiency and accuracy in chemical management is necessary.

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：ELSEVIER IRELAND LTD  

Drug-induced renal tubular injury is one of the major concerns in preclinical safety evaluations. Toxicogenomics is becoming a generally accepted approach for identifying chemicals with potential safety problems. In the present study, we analyzed 33 nephrotoxicants and 8 non-nephrotoxic hepatotoxicants to elucidate time- and dose-dependent global gene expression changes associated with proximal tubular toxicity. The compounds were administered orally or intravenously once daily to male Sprague-Dawley rats. The animals were exposed to four different doses of the compounds, and kidney tissues were collected on days 4, 8, 15, and 29. Gene expression profiles were generated from kidney RNA by using Affymetrix GeneChips and analyzed in conjunction with the histopathological changes. We used the filter-type gene selection algorithm based on t-statistics conjugated with the SVM classifier, and achieved a sensitivity of 90% with a selectivity of 90%. Then, 92 genes were extracted as the genomic biomarker candidates that were used to construct the classifier. The gene list contains well-known biomarkers, such as Kidney injury molecule 1, Ceruloplasmin, Clusterin, Tissue inhibitor of metallopeptidase 1, and also novel biomarker candidates. Most of the genes involved in tissue remodeling, the immune/inflammatory response, cell adhesion/proliferation/migration, and metabolism were predominantly up-regulated. Down-regulated genes participated in cell adhesion/proliferation/migration, membrane transport, and signal transduction. Our classifier has better prediction accuracy than any of the well-known biomarkers. Therefore, the toxicogenomics approach would be useful for concurrent diagnosis of renal tubular injury. (c) 2009 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.tox.2009.09.003

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

A large-scale transcriptome database of rat liver (TG-GATEs) has been established by the Toxicogenomics Project in Japan. In the present study, we focused on 8 hepatotoxic compounds within TG-GATES, i.e., clofibrate, omeprazole, ethionine, thioacetamide, benzbromarone, propylthiouracil, Wy-14,643 and amiodarone, which induced coagulation abnormalities. Aspirin was selected as a reference compound that directly causes coagulation abnormality, but not through liver toxicity. In blood chemical examinations, for all the coagulopathic compounds there was little elevation of aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT), suggesting no severe cell death by treatment with the compounds. We extracted 344 probe sets from the data for these 8 typical drugs, which induced this phenotype at any time from 3 to 28 days of repeated administration. Principal component analysis using these probe sets clearly separated dose- and time-dependent clusters of the treated groups from their controls, except aspirin and propylthiouracil, both of which were considered to cause coagulopathy not due to their hepatotoxicity but due to their direct effects on the blood coagulation system. Reviewing the extracted genes, changes in lipid metabolism were found to be dominant. Genes related to blood coagulation were generally down-regulated by these drugs except that vitamin K epoxide reductase complex subunit 1 (Vkorc1) like 1, a paralogous gene of Vkorc1, was up-regulated. As expected, expression changes of these genes were least prominent in aspirin or propylthiouracil-treated liver. We concluded that these probe sets could be a good starting point in developing mechanism-based biomarkers for diagnosis or prognosis of hepatotoxicity-related coagulation abnormalities in the early stage of drug development.

DOI： 10.2131/jts.34.281

Web of Science

Scopus

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：ELSEVIER IRELAND LTD  

For assessing carcinogenicity in animals, it is difficult and costly, an alternative strategy has been desired. We explored the possibility of applying a toxicogenomics approach by using comprehensive gene expression data in rat liver treated with various compounds. As prototypic non-genotoxic hepatocarcinogens, thioacetamide (TAA) and methapyrilene (MP) were selected and 349 commonly changed genes were extracted by statistical analysis. Taking both compounds as positive with six compounds, acetaminophen, aspirin, phenylbutazone, rifampicin, alpha-naphthylisothiocyanate, and amiodarone as negative, prediction analysis of microarray (PAM) was performed. By training and 10-fold cross validation, a classifier containing 112 probe sets that gave an overall success rate of 95% was obtained. The validity of the present discriminator was checked for 30 chemicals. The PAM score showed characteristic time-dependent increases by treatment with several non-genotoxic hepatocarcinogens, including TAA, MP, coumarin, ethionine and WY-14643, while almost all of the non-carcinogenic samples were correctly predicted. Measurement of hepatic glutathione content suggested that IMP and TAA cause glutathione depletion followed by a protective increase, but the protective response is exhausted during repeated administration. Therefore, the presently obtained PAM classifier could predict potential non-genotoxic hepatocarcinogenesis within 24 h after single dose and the inevitable pseudo-positives could be eliminated by checking data of repeated administrations up to 28 days. Tests for carcinogenicity using rats takes at least 2 years, while the present work suggests the possibility of lowering the time to 28 days with high precision, at least for a category of non-genotoxic hepatocarcinogens causing oxidative stress. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.tox.2008.05.013

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

We have constructed a large-scale transcriptome database of rat liver treated with various drugs. In an effort to identify a biomarker for diagnosis of hepatic phospholipidosis, we extracted 78 probe sets of rat hepatic genes from data of 5 drugs, amiodarone, amitriptyline, clomipramine, imipramine, and ketoconazole, which actually induced this phenotype. Principal component analysis (PCA) using these probes clearly separated dose- and time-dependent clusters of treated groups from their controls. Moreover, 6 drugs (chloramphenicol, chlorpromazine, gentamicin, perhexiline, promethazine, and tamoxifen), which were reported to cause phospholipidosis but judged as negative by histopathological examination, were designated as positive by PCA using these probe sets. Eight drugs (carbon tetrachloride, coumarin, tetracycline, metformin, hydroxyzine, diltiazem, 2-bromoethylamine, and ethionamide), which showed phospholipidosis-like vacuolar formation in the histopathology, could be distinguished from the typical drugs causing phospholipidosis. Moreover, the possible induction of phospholipidosis was predictable by the expression of these genes 24 h after single administration in some of the drugs. We conclude that these identified 78 probe sets could be useful for diagnosis of phospholipidosis, and that toxicogenomics would be a promising approach for prediction of this type of toxicity. (c) 2008 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.taap.2008.01.036

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPANESE SOC TOXICOLOGICAL SCIENCES  

The present sandy was conducted as a model case of the toxicogenomics approach for analyzing toxicological mechanisms and toxicity assessments in the early stage of drug development by comparing with classical toxicology data. Methapyrilene (MP) 100 mg/k produced obvious histopathological changes in liver of rats by single or repeated dose up to 28 days with significant elevation of ALT and AST. In the middle dose groups (30 mg/kg MP), no apparent changes were noted in blood biochemical data by single closing or repeated closing up to one week, and no obvious histopathological changes were observed except a slight hypertrophy in the hepatocytes. Comprehensive gene expression changes were analyzed using Affymetrix GeneChip(R) and differentially expressed probe sets were statistically extracted. These contained many genes related to "glutathione metabolism", "apoptosis". "MAPK signaling pathway" and "regulation of cell cycle", which were all thought to be involved in the development of presently observed phenotypes. In the high dose groups, TGP1 scores (developed in our system in order to overview the responsiveness of drugs to multiple marker gene lists) for these categories were markedly increased from the early time point. after single dose and kept their high expression throughout the repeated dose period. In the middle dose groups, the increment of the scores were noted not only at the dine points when apparent pathological changes emerged. but also at the earlier stage of repeated dosing and even after single dosing. We conclude that toxicogenomics would enable a more sensitive assessment at the earlier time point than classical toxicology evaluation.

DOI： 10.2131/jts.33.37

Web of Science

Scopus

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：5  

To identify candidate biomarker gene sets to evaluate the potential risk of chemical-induced glutathione depletion in livers, we conducted microarray analysis on rat livers administered with phorone (40, 120 and 400 mg/kg), a prototypical glutathione depletor. Hepatic glutathione content was measured and glutathione depletion-responsive gene probe sets (GSH probe sets) were identified using Affymetrix Rat Genome 230 2.0 GeneChip by the following procedure. First, probe sets, whose signal values were inversely correlated with hepatic glutathione content throughout the experimental period, were statistically identified. Next, probe sets, whose average signal values were greater than 1.5-fold compared to those of controls 3 hr after phorone treatment, were selected. Finally, probe sets without unique Entrez Gene ID were removed, ending up with 161 probe sets in total. The usefulness of the identified GSH probe sets was verified by a toxicogenomics database. It was shown that signal profiles of the GSH probe sets in rats treated with bromobenzene were strongly altered compared with other chemicals. Focusing on bromobenzene, time-course profiles of hepatic glutathione content and gene expression revealed that the change in gene expression profile was marked after the bromobenzene treatment, whereas hepatic glutathione content had recovered after initial acute depletion, suggesting that the gene expression profile did not reflect the hepatic glutathione content itself, but rather reflects a perturbation of glutathione homeostasis. The identified GSH probe sets would be useful for detecting glutathione-depleting risk of chemicals from microarray data.

DOI： 10.2131/jts.32.469

Scopus

PubMed

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：4  

We have constructed a large-scale transcriptome database of rat liver treated with various drugs. In an effort to identify a biomarker for interpretation of plasma triglyceride (TG) decrease, we extracted 218 probe sets of rat hepatic genes from data of 15 drugs that decreased the plasma TG level but differentially affected food consumption. Pathway and gene ontology analysis revealed that the genes belong to amino acid metabolism, lipid metabolism and xenobiotics metabolism. Principal component analysis (PCA) showed that 12 out of 15 compounds were separated in the direction of PC1, and these 12 were separated in the direction of PC2, according to their hepatic gene expression profiles. It was found that genes with either large or small eigenvector values in principal component PC 2 were those reported to be regulated by peroxisome proliferator-activated receptor (PPAR)α or constitutive androstane receptor (CAR), respectively. In fact, WY-14,643, clofibrate, gemfibrozil and benzbromarone, reported to be PPARα activators, distributed to the former, whereas propylthiouracil, omeprazole, phenobarbital, thioacetamide, methapyrilene, sulfasalazine and coumarin did to the latter. We conclude that these identified 218 probe sets could be a useful source of biomarkers for classification of plasma TG decrease, based on the mechanisms involving PPARα and CAR.

DOI： 10.2131/jts.32.387

Scopus

PubMed

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：5  

The Toxicogenomics project has been constructing a large-scale database of about 150 compounds exposed to rat (single dose, 3, 6, 9, 24 hrs and repeated dose for 3, 7, 14 28 days with 3 dose levels) and rat hepatocytes (2, 8, 24 hr with 3 concentrations) and data of transcriptome in liver using GeneChip, and the related toxicological measures are being accumulated. In the present study, the data of three ligands of peroxisome proliferator activated receptor α (PPARα), i.e., clofibrate, WY-14643 and gemfibrozil in our database were analyzed. Many of the β-oxidation-related genes were commonly induced in vivo and in vitro, whereas expression changes in genes related to cell proliferation, apoptosis, were detected in vivo (single and repeated dose) but not in vitro. Changes in those related to the immune response, coagulation and the stress response were also detectable exclusively in vivo. Using the genes mobilized in two or three PPARα agonists, hierarchical clustering was performed on 32 compounds stored in our database. In the profiling of an in vivo single dose, benzbromarone and aspirin were located in the same cluster of the three PPARα agonists. The clustering of in vitro data revealed that benzbromarone, three NSAIDs (aspirin, indomethacin and diclofenac sodium) and valproic acid belonged to the same cluster of PPARα agonists, supporting the reports that benzbromarone,valproic acid and some NSAIDs were reported to be PPARα agonists. Using the genes commonly up-regulated both in vivo and in vitro, principal component analysis was performed in 32 compounds, and principal component 1 was found to be the convenient parameter to extract PPARα agonist-like compounds from the database.

DOI： 10.2131/jts.31.471

Scopus

PubMed

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：5  

In The Toxicogenomics Project, about 150 chemicals are administered to rats, and gene expression in the liver analyzed by Affymetrix GeneChip and stored in the database. As the quality of RNA greatly influences the accuracy of gene expression data, conditions of the storage of the sample are very important. Recently, an RNA stabilization solution, RNAlater®, has become commercially available. In this study, the new storage method was compared with the traditional storage method (stored in freezer or liquid nitrogen) under various conditions by looking at the degradation of RNA assessed by its total yield, OD260/280 ratio, 28S/18S ratio, and quantity of β-actin. It was confirmed that RNAlater® preserved the liver tissue sample by maintaining the quality of RNA for one year (in liquid N2 or -80°C), for 3 days (4°C), or for 2 hr (room temperature) without degradation of RNA. Quality of RNA samples dissolved in buffer RLT and stored at -20°C tended to decrease, but samples stored at -80°C were almost equivalent to those stored in liquid nitrogen. In conclusion, we recommend the following procedure for preservation of liver tissue for extraction of RNA: 1) tissues removed should be put into chilled RNAlater® as soon as possible
2) samples in RNAlater® must be stored overnight or longer at 4°C and can be left for as long as 2 weeks without freezing
3) samples in RNAlater® can be stored for at least one year under less than -.20°C and 4) samples dissolved in buffer RLT can be preserved at least for one year under -80°C.

DOI： 10.2131/jts.31.509

Scopus

PubMed

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：5  

A large-scale toxicogenomcis database has now been constructed in the Toxicogenomics Project in Japan (TGP). To facilitate the analytical procedures for such large-scale microarray data, we developed a simple one-dimensional score, named TGP1 which expresses the trend of the changes in expression of biomarker genes as a whole. To evaluate the usefulness of the TGP1 score, microarray data of rat liver and rat hepatocytes deposited in the TGP database were scored for three biomarker gene sets, i.e., carcinogenesis-related, PPARα-regulated and glutathione depletion-related gene sets. The TGP1 scoring system gave reasonable results, i.e., the scores for carcinogenesis-related genes were high in omeprazole-, chlorpromazine-, hexachlorobenzene-, sulfasalazine- and Wy-14,643-treated rat livers, that for PPARα-regulated genes were high in clofibrate-, Wy-14,643-, gemfibrozil-, benzbromarone- and aspirin-treated rat livers as well as rat hepatocytes, and for glutathione deficiency-related genes were high in omeprazole-, bromobenzene-, acetaminophen- and coumarin-treated rat liver. We concluded that the TGP1 score is useful for surveying the expression changes in multiple biomarker gene sets for a large-scale toxicogenomics database, which would reduce the time of doing conventional multivariate statistical analysis. In addition, the TGP1 score can be applied to screening of compatible biomarker gene sets between rat liver and rat hepatocytes, like PPARα-regulated gene sets, which will allow us to develop an appropriate in vitro system for drug safety assessment in vivo.

DOI： 10.2131/jts.31.433

Scopus

PubMed

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：5  

The aim of this study was to compare gene expression profiles in the different kidney regions as the basis for toxicogenomics. Rat kidney was separated into papilla, medulla and cortex, and total RNA was isolated from these and from the whole slice. Gene expression profiling was performed using Affymetrix Rat Genome 230 2.0 Array. When global normalization was applied, the expression of β-actin or GAPDH varied among the regions. It was considered that such a comparison could not be made, especially between papilla and other portions, since the production of total mRNA in the former was relatively low. In fact, ANOVA was performed on the gene expression values with global normalization in papilla, medulla, cortex, and whole slice, and the numbers of genes appeared to be the highest in papilla. It was also observed that many genes showed their maximum or minimum in the whole slice, which was theoretically impossible. To overcome the problems associated with global normalization, the "percelome" normalization (a way to obtain the values directly related to the copies of mRNA per cell) was employed to compare the regions. In applying this procedure, probe sets with regional difference in expression were efficiently extracted by ANOVA. When they were sorted by the fold difference to other regions, the higher rank was occupied by genes characteristic of the functions of kidney, i.e., channels, transporters and metabolic enzymes. Some of them were consistent with the literature and were related to pathophysiological phenomena. Comprehensive comparison of data of gene expression in the renal anatomical area will greatly enhance studies of the physiological function and mechanism of toxicity in kidney.

DOI： 10.2131/jts.31.449

Scopus

PubMed

CiNii Article

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：BIOMED CENTRAL LTD  

Background: Transcriptome data from quantitative PCR (Q-PCR) and DNA microarrays are typically obtained from a fixed amount of RNA collected per sample. Therefore, variations in tissue cellularity and RNA yield across samples in an experimental series compromise accurate determination of the absolute level of each mRNA species per cell in any sample. Since mRNAs are copied from genomic DNA, the simplest way to express mRNA level would be as copy number per template DNA, or more practically, as copy number per cell.
Results: Here we report a method (designated the "Percellome" method) for normalizing the expression of mRNA values in biological samples. It provides a "per cell" readout in mRNA copy number and is applicable to both quantitative PCR (Q-PCR) and DNA microarray studies. The genomic DNA content of each sample homogenate was measured from a small aliquot to derive the number of cells in the sample. A cocktail of five external spike RNAs admixed in a dose-graded manner (dose-graded spike cocktail; GSC) was prepared and added to each homogenate in proportion to its DNA content. In this way, the spike mRNAs represented absolute copy numbers per cell in the sample. The signals from the five spike mRNAs were used as a dose-response standard curve for each sample, enabling us to convert all the signals measured to copy numbers per cell in an expression profile-independent manner. A series of samples was measured by Q-PCR and Affymetrix GeneChip microarrays using this Percellome method, and the results showed up to 90% concordance.
Conclusion: Percellome data can be compared directly among samples and among different studies, and between different platforms, without further normalization. Therefore, "percellome" normalization can serve as a standard method for exchanging and comparing data across different platforms and among different laboratories.

DOI： 10.1186/1471-2164-7-64

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）   出版者・発行元：JAPAN SOC ANALYTICAL CHEMISTRY  

Because concern over endocrine disrupting reactions caused by chemicals to humans and animals is growing, a rapid and reliable screening assay for endocrine disrupting chemicals is required. We have developed an in vitro screening assay based on a hormone receptor mechanism using a surface plasmon resonance (SPR) sensor. The interaction between an estrogen receptor alpha (ER) and an estrogen response element (ERE) is monitored in real time, when ER is injected over the SPR sensor chip on which a DNA fragment containing ERE is immobilized. In the presence of a chemical with estrogenic activity, the ER-ERE interaction is enhanced and the kinetic parameters are altered. We have validated the assay in terms of its specificity, dose dependency, optimal reaction conditions and reproducibility. It has been shown that the assay is very reliable as a rapid and quantitative screening method to judge the estrogenic activities of chemicals.

DOI： 10.2116/analsci.20.611

Web of Science

Scopus

PubMed

researchmap

記述言語：日本語   出版者・発行元：The Japanese Society for Lymphoreticular Tissue Research  

DOI： 10.3960/jslrt1961.36.217

CiNii Article

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2016.07.546

Web of Science

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2016.06.1538

Web of Science

researchmap

記述言語：英語   出版者・発行元：国立医薬品食品衛生研究所安全情報部  

© 2016, National Institute of Health Sciences. All rights reserved. Under the Chemical Substances Control Law in Japan, initial hazard information on existing chemical substances is collected by the Ministry of Health, Labour and Welfare, Japan to assess potential initial risks to human health. This hazard information includes acute toxicity, repeated-dose toxicity, genotoxicity, and/or reproductive/developmental toxicity. In an attempt to disseminate such information more widely, we have been reporting this information. In the present report, a summary of hazard information is presented for the following five existing chemical substances: 2,3,4,4′-tetrahydr oxybenzophenone (CAS: 31127-54-5); 1-propene, tetramer (CAS: 6842-15-5); 4-chlorobenzaldehyde (CAS: 104-88-1); diammonium hydrogen 2-hydroxypropane-1,2,3-tricarboxylate (CAS: 3012-65-5); and 2-nitrop- cresol (CAS: 119-33-5). Additionally, we created a dossier for the clarification and evaluation of each study in English using the International Uniform Chemical Information Database version 5.

Scopus

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：WILEY-BLACKWELL  

Perfluoroalkyl carboxylic acids (PFCAs) are a series of environmental contaminants that have received attention because of their possible adverse effects on wildlife and human health. Although many toxicological studies have been performed on perfluorooctanoic acid with carbon chain length C8, available toxicity data on PFCAs with longer chains are still insufficient to evaluate their hazard. A combined repeated dose and reproductive/developmental toxicity screening study for perfluorododecanoic acid (PFDoA; C12) was conducted in accordance with OECD guideline 422 to fill these toxicity data gaps. PFDoA was administered by gavage to male and female rats at 0.1, 0.5, or 2.5 mg/kg/day. The administration of PFDoA at 0.5 and 2.5 mg/kg/day for 42-47 days mainly affected the liver, in which hypertrophy, necrosis, and inflammatory cholestasis were noted. Body weight gain was markedly inhibited in the 2.5 mg/kg/day group, and a decrease in hematopoiesis in the bone marrow and atrophic changes in the spleen, thymus, and adrenal gland were also observed. Regarding reproductive/developmental toxicity, various histopathological changes, including decreased spermatid and spermatozoa counts, were observed in the male reproductive organs, while continuous diestrous was observed in the females of the 2.5 mg/kg/day group. Seven of twelve females receiving 2.5 mg/kg/day died during late pregnancy while four other females in this group did not deliver live pups. No reproductive or developmental parameters changed at 0.1 or 0.5 mg/kg/day. Based on these results, the NOAELs of PFDoA were concluded to be 0.1 mg/kg/day for repeated dose toxicity and 0.5 mg/kg/day for reproductive/developmental toxicity. (C) 2014 Wiley Periodicals, Inc.

DOI： 10.1002/tox.21996

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

DOI： 10.1016/j.yrtph.2015.07.002

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2015.08.969

Web of Science

researchmap

記述言語：英語  

© 2015 Taylor &amp; Francis. Using the procedure devised by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), we performed safety evaluations on five acetal flavouring substances uniquely used in Japan: acetaldehyde 2,3-butanediol acetal, acetoin dimethyl acetal, hexanal dibutyl acetal, hexanal glyceryl acetal and 4-methyl-2-pentanone propyleneglycol acetal. As no genotoxicity study data were available in the literature, all five substances had no chemical structural alerts predicting genotoxicity. Using Cramer’s classification, acetoin dimethyl acetal and hexanal dibutyl acetal were categorised as class I, and acetaldehyde 2,3-butanediol acetal, hexanal glyceryl acetal and 4-methyl-2-pentanone propyleneglycol acetal as class III. The estimated daily intakes for all five substances were within the range of 1.45–6.53 µg/person/day using the method of maximised survey-derived intake based on the annual production data in Japan from 2001, 2005, 2008 and 2010, and 156–720 µg/person/day using the single-portion exposure technique (SPET), based on the average use levels in standard portion sizes of flavoured foods. The daily intakes of the two class I substances were below the threshold of toxicological concern (TTC) – 1800 μg/person/day. The daily intakes of the three class III substances exceeded the TTC (90 μg/person/day). Two of these, acetaldehyde 2,3-butanediol acetal and hexanal glyceryl acetal, were expected to be metabolised into endogenous products after ingestion. For 4-methyl-2-pentanone propyleneglycol acetal, one of its metabolites was not expected to be metabolised into endogenous products. However, its daily intake level, based on the estimated intake calculated by the SPET method, was about 1/15 000th of the no observed effect level. It was thus concluded that all five substances raised no safety concerns when used for flavouring foods at the currently estimated intake levels. While no information on in vitro and in vivo toxicity for all five substances was available, their metabolites were judged as raising no safety concerns at the current levels of intake.

DOI： 10.1080/19440049.2015.1067927

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：OXFORD UNIV PRESS  

Toxicogenomics focuses on assessing the safety of compounds using gene expression profiles. Gene expression signatures from large toxicogenomics databases are expected to perform better than small databases in identifying biomarkers for the prediction and evaluation of drug safety based on a compound's toxicological mechanisms in animal target organs. Over the past 10 years, the Japanese Toxicogenomics Project consortium (TGP) has been developing a large-scale toxicogenomics database consisting of data from 170 compounds (mostly drugs) with the aim of improving and enhancing drug safety assessment. Most of the data generated by the project (e.g. gene expression, pathology, lot number) are freely available to the public via Open TG-GATEs (Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System). Here, we provide a comprehensive overview of the database, including both gene expression data and metadata, with a description of experimental conditions and procedures used to generate the database. Open TG-GATEs is available from http://toxico.nibio.go.jp/english/index.html.

DOI： 10.1093/nar/gku955

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：National Institute of Health Sciences  

Under the Chemical Substances Control Law（CSCL）in Japan, initial hazard information for existing chemical substances has been collected by the Ministry of Health, Labour and Welfare, Japan（MHLW） to assess potential initial risks to human health. We have reviewed all collected toxicity information pertaining to acute toxicity, repeated dose toxicity, genotoxicity, and/or reproductive/developmental toxicity and performed hazard assessments. Approximately 150 substances are currently undergoing review and assessment. For clarification and evaluation of each toxicity study, we have created a dossier（a collection of study data containing a detailed summary of the methods, results, and conclusions of each study）in English using the International Uniform Chemical Information Database （IUCLID）version 5. The IUCLID dossier format is widely used and has been accepted as one of the most beneficial formats for providing summarized chemical substance toxicity assessments. In this report, as a contribution to our ongoing hazard assessment activity, we present summary hazard information related to the potential human health effects of the following 5 chemical substances: 4-chlorobenzoyl chloride（CAS: 122-01-0）
benzenesulfonic acid, 4-hydroxy-, tin（2+）salt（CAS: 70974- 33-3）
chlorocyclohexane（CAS: 542-18-7）
1,3-cyclohexanedimethanamine（CAS: 2579-20-6）
and 1,3,5-triazine-2,4,6（1H,3H,5H）-trithione（CAS: 638-16-4）. The IUCLID dossiers created for these 5 chemical substances will be made available via the Japan Existing Chemical Data Base（JECDB）at &lt
http://dra4.nihs.go.jp/mhlw_data/jsp/SearchPageENG.jsp&gt
. Additional human health hazard information on existing chemical substances will be provided using the same methodology and website when it is available.

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：Japanese Society of Toxicology  

Recent studies have shown that epigenetic alterations correlate with carcinogenesis in various tissues. Identification of these alterations might help characterize the early stages of carcinogenesis. We comprehensively analyzed DNA methylation and gene expression in livers obtained from rats exposed to nitrosodiethylamine (DEN) followed by a promoter of hepatic carcinogenesis, phenobarbital (PB). The combination of DEN and PB induced marked increases in number and area of glutathione S-transferase-placental form (GST-P)-positive foci in the liver. In the liver of rats that received 30 mg/kg of DEN, pathway analysis revealed alterations of common genes in terms of gene expression and DNA methylation, and that these alterations were related to immune responses. Hierarchical clustering analysis of the expression of common genes from public data obtained through the Toxicogenomics Project-Genomics Assisted Toxicity Evaluation system (TG-GATEs) showed that carcinogenic compounds clustered together. MBD-seq and GeneChip analysis indicated that major histocompatibility complex class Ib gene RT1-CE5, which has an important role in antigen presentation, was hypomethylated around the promoter region and specifically induced in the livers of DEN-treated rats. Further, immunohistochemical analysis indicated that the co-localization of GST-P and protein homologous to RT1-CE5 was present at the foci of some regions. These results suggest that common genes were altered in terms of both DNA methylation and expression in livers, with preneoplastic foci indicating carcinogenic potential, and that immune responses are involved in early carcinogenesis. In conclusion, the present study identified a specific profile of DNA methylation and gene expression in livers with preneoplastic foci. Early epigenetic perturbations of immune responses might correlate with the early stages of hepatocarcinogenesis.

DOI： 10.2131/jts.39.837

Scopus

PubMed

researchmap

記述言語：英語  

© 2014 Elsevier B.V. Hydroquinone (HQ) is used in skin bleaching agents, hair dyes, and finger nail treatments. Many skin-lightening cosmetics that contain HQ are currently marketed in Japan. Concerns have been expressed regarding health risks to the general population because the carcinogenicity of HQ was previously suggested in animal studies. HQ induced hepatocellular adenomas and forestomach hyperplasias in mice and renal tubular cell adenomas in male rats. In the present study, the lacZ transgenic mutation assay was conducted according to OECD test guideline 488 to determine whether mutagenic mechanisms were involved in HQ-induced carcinogenesis. Male Muta™ mice were repeatedly administered HQ orally at dosages of 0, 25, 50, 100, or 200. mg/kg bw/day for 28 days. Body weight gain was decreased in all treatment groups. No significant differences were observed in mutant frequencies in the liver, stomach, lung, or kidney between HQ-treated mice and the concurrent negative controls, whereas the significant induction of mutations was noted in the positive control, N-ethyl-. N-nitrosourea. These results suggest that a mutagenic mechanism is not responsible for HQ-induced carcinogenesis.

DOI： 10.1016/j.mrgentox.2014.10.009

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

We propose a category approach to assessing the testicular toxicity of chemicals with a similar structure to ethylene glycol methyl ether (EGME). Based on toxicity information for EGME and related chemicals and accompanied by adverse outcome pathway information on the testicular toxicity of EGME, this category was defined as chemicals that are metabolized to methoxy- or ethoxyacetic acid, a substance responsible for testicular toxicity. A Japanese chemical inventory was screened using the Hazard Evaluation Support System, which we have developed to support a category approach for predicting the repeated-dose toxicity of chemical substances. Quantitative metabolic information on the related chemicals was then considered, and seventeen chemicals were finally obtained from the inventory as a shortlist for the category. Available data in the literature shows that chemicals for which information is available on the metabolic formation of EGME, ethylene glycol ethyl ether, methoxy- or ethoxyacetic acid do in fact possess testicular toxicity, suggesting that testicular toxicity is a concern, due to metabolic activation, for the remaining chemicals. Our results clearly demonstrate practical utility of AOP-based category approach for predicting repeated-dose toxicity of chemicals. (C) 2014 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.yrtph.2014.10.011

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：ELSEVIER IRELAND LTD  

Drug-induced liver injury (DILI) is a significant safety issue associated with medication use, and is the major cause of failures in drug development and withdrawal in post marketing. Cytokines are signaling molecules produced and secreted by immune cells and play crucial roles in the progression of DILI. Although there are numerous reports of cytokine changes in several DILI models, a comprehensive analysis of cytokine expression changes in rat liver injury induced by various compounds has, to the best of our knowledge, not been performed. In the past several years, we have built a public, free, large-scale toxicogenomics database, called Open TG-GATEs, containing microarray data and toxicity data of the liver of rats treated with various hepatotoxic compounds. In this study, we measured the protein expression levels of a panel of 24 cytokines in frozen liver of rats treated with a total of 20 compounds, obtained in the original study that formed the basis of the Open TG-GATEs database and analyzed protein expression profiles combined with mRNA expression profiles to investigate the correlation between mRNA and protein expression levels. As a result, we demonstrated significant correlations between mRNA and protein expression changes for interleukin (IL)-1 beta, IL-1 alpha, monocyte chemo-attractant protein (MCP)-1/CC-chemokine ligand (Ccl)2, vascular endothelial growth factor A (VEGF-A), and regulated upon activation normal T cell expressed and secreted (RANTES)/Ccl5 in several different types of DILI. We also demonstrated that IL-1 beta protein and MCP-1/Ccl2 mRNA were commonly up-regulated in the liver of rats treated with different classes of hepatotoxicants and exhibited the highest accuracy in the detection of hepatotoxicity. The results also demonstrate that hepatic mRNA changes do not always correlate with protein changes of cytokines in the liver. This is the first study to provide a comprehensive analysis of mRNA protein correlations of factors involved in various types of DILI, as well as additional insights into the importance of understanding complex cytokine expression changes in assessing DILI. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.tox.2014.07.005

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：WILEY-BLACKWELL  

Nephrotoxicity is a common side effect observed during both nonclinical and clinical drug development investigations. The present study aimed to identify metabolomic biomarkers that could provide early and sensitive indication of nephrotoxicity in rats. Metabolomic analyses were performed using capillary electrophoresis-time-of-flight mass spectrometry on rat plasma collected at 9 and 24 h after a single dose of 2-bromoethylamine or n-phenylanthranilic acid and at 24 h after 7 days of repeated doses of gentamicin, cyclosporine A or cisplatin. Among a total of 169 metabolites identified, 3-methylhistidine (3-MH), 3-indoxyl sulfate (3-IS) and guanidoacetate (GAA) were selected as candidate biomarkers. The biological significance and reproducibility of the observed changes were monitored over time in acute nephrotoxicity model rats treated with a single dose of cisplatin, with the glomerular filtration rate monitored by determination of creatinine clearance. Increased plasma levels of 3-MH and 3-IS were related to a decline in glomerular filtration due to a renal failure. In contrast, the decrease in plasma GAA, which is synthesized from arginine and glycine in the kidneys, was considered to reflect decreased production due to renal malfunction. Although definitive validation studies are required to confirm their usefulness and reliability, 3-MH, 3-IS and GAA may prove to be valuable plasma biomarkers for monitoring nephrotoxicity in rats. Copyright (C) 2013 John Wiley & Sons, Ltd.

DOI： 10.1002/jat.2933

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2014.06.566

Web of Science

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2014.06.786

Web of Science

researchmap

記述言語：英語   出版者・発行元：WILEY-BLACKWELL  

Historical control data on rodent developmental toxicity studies, performed between 1994 and 2010, were obtained from 19 laboratories in Japan, including 10 pharmaceutical and chemical companies and nine contract research organizations. Rats, mice, and hamsters were used for developmental toxicity studies. Data included maternal reproductive findings at terminal cesarean sections and fetal findings including the spontaneous incidences of external, visceral, and skeletal anomalies. No noticeable differences were observed in maternal reproductive data between laboratories. Inter-laboratory variations in the incidences of fetuses with anomalies appeared to be due to differences in the selection of observation parameters, observation criteria, classification of the findings, and terminology of fetal alterations. Historical control data are useful for the appropriate interpretation of experimental results and evaluation of the effects of chemical on reproductive and developmental toxicities.

DOI： 10.1111/cga.12050

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD  

Using the procedure devised by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), we performed safety evaluations on four flavoring substances structurally related to menthol (L-menthyl 2-methylbutyrate, DL-menthyl octanoate, DI-menthyl palmitate, and DL-menthyl stearate) uniquely used in Japan. While no genotoxicity study data were available in the literature, all four substances had no chemical structural alerts predictive of genotoxicity. Moreover, they all four are esters consisting of menthol and simple carboxylic acids that were assumed to be immediately hydrolyzed after ingestion and metabolized into innocuous substances for excretion. As menthol and carboxylic acids have no known genotoxicity, it was judged that the JECFA procedure could be applied to these four substances. According to Cramer's classification, these substances were categorized as class I based on their chemical structures. The estimated daily intakes for all four substances were within the range of 1.54-4.71 mu g/person/day and 60-1250 mu g/person/day, using the methods of Maximized Survey-Derived Intake and Single Portion Exposure Technique, respectively, based on the annual usage data of 2001, 2005, and 2010 in Japan. As the daily intakes of these substances were below the threshold of concern applied to class I substances viz., 1800 mu g/person/day, it was concluded that all four substances raise no safety concerns when used for flavoring foods under the currently estimated intake levels. (C) 2013 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.fct.2013.11.044

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：Japanese Society of Toxicology  

We previously reported a toxicogenomics-based prediction model for hepatocarcinogens in which the expression patterns of signature genes following repeated doses of either genotoxic or non-genotoxic compounds were similar. Based on the results of our prediction model, we hypothesized that repeated doses of non-genotoxic carcinogens might have initiating potential. Here, we conducted a two-stage hepatocarcinogenesis study in rats exposed to the initiating agent nitrosodiethylamine (DEN), and hepatotoxic compounds thioacetamide (TAA), methapyrilene (MP) and acetaminophen (APAP) for 1-2 weeks followed by the liver tumor promoter phenobarbital (PB). The duration of initial treatment was determined based on positive results from our prediction model. Combined treatment of 3 or 30 mg/kg of genotoxic DEN and PB induced marked increases in altered hepatocellular foci and a DEN dose-dependent increase in the number and area of glutathione S-transferase-placental form (GST-P)-positive foci. A low number of altered hepatocellular foci were also observed in rats treated with TAA at a dose of 45 mg/kg. MP at a dose of 100 mg/kg induced a very low number of foci, but APAP did not. Hierarchical clustering analysis using gene expression data revealed that 2-week treatment with TAA at a dose of 30 mg/kg and MP at 45 mg/kg induced specific expression of DNA damage-related genes, similar to 1-week treatment with DEN at a dose of 30 mg/kg. These results suggest that TAA and MP induce DNA damage, which partially supports our hypothesis. Although this study does not indicate whether tumor growth in response to these compounds can be assessed in this model, our results suggest that cumulative treatment with non-genotoxic TAA might have initiating potential in the liver.

DOI： 10.2131/jts.39.785

Scopus

PubMed

researchmap

記述言語：英語  

Perfluoroalkyl acids (PFAAs) are environmental contaminants that have received attention because of their possible effects on wildlife and human health. In order to obtain initial risk information on the toxicity of perfluoroundecanoic acid (PFUA), we conducted a combined repeated dose toxicty study with the reproduction/developmental toxicity screening test (OECD test guideline 422). PFUA was administered by gavage to rats at 0 (vehicle: corn oil), 0.1, 0.3 or 1.0 mg/kg/day. At 1.0 mg/kg/day, body weight gain was inhibited in both sexes, and there was a decrease in fibrinogen in both sexes and shortening of the activated partial thromboplastin time in males. An increase in blood urea nitrogen and a decrease in total protein in both sexes and increases in alkaline phosphatase and alanine transaminase and a decrease in albumin in males were observed at 1.0 mg/kg/day. Liver weight was increased in males at 0.3 mg/kg/day and above and in females at 1.0 mg/kg/day, and this change was observed after a recovery period. In both sexes, centrilobular hypertrophy of hepatocytes was observed at 0.3 mg/kg/day and above and focal necrosis was observed at 1.0 mg/kg/day. In reproductive/developmental toxicity, body weight of pups at birth was lowered and body weight gain at 4 days after birth was inhibited at 1.0 mg/kg/day, while no dose-related changes were found in the other parameters. Based on these findings, the no observed adverse effect levels (NOAELs) for the repeated dose and reproductive/developmental toxicity were considered to be 0.1 mg/kg/day and 0.3 mg/kg/day, respectively.

DOI： 10.2131/jts.39.97

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：NATURE PUBLISHING GROUP  

MicroRNAs (miRNAs) are small (similar to 22 nucleotide) noncoding RNAs that play pivotal roles in regulation of gene expression. The value of miRNAs as circulating biomarkers is now broadly recognized; such tissue-specific biomarkers can be used to monitor tissue injury and several pathophysiological conditions in organs. In addition, miRNA profiles of normal organs and tissues are important for obtaining a better understanding of the source of modulated miRNAs in blood and how those modulations reflect various physiological and toxicological conditions. This work was aimed at creating an miRNA atlas in rats, as part of a collaborative effort with the Toxicogenomics Informatics Project in Japan (TGP2). We analyzed genome-wide miRNA profiles of 55 different organs and tissues obtained from normal male rats using miRNA arrays. The work presented herein represents a comprehensive dataset derived from normal samples profiled in a single study. Here we present the whole dataset with miRNA profiles of multiple organs, as well as precise information on experimental procedures and organ-specific miRNAs identified in this dataset.

DOI： 10.1038/sdata.2014.5

Web of Science

Scopus

PubMed

researchmap

記述言語：日本語   出版者・発行元：FOOD HYGIENE & SAFETY  

Basic principles for simulation of acute reference dose (ARfD) setting were defined based on the work of Solecki et al. (2005). The principles are: (1) Appearance of acute toxicity within 24 h after oral administration. (2) Rationale for setting toxicity that appears or could appear after single oral administration. (3) ARfD setting is assumed to be necessary for all pesticides. (4) ARfD setting is not necessary when the value is at or above the cutoff level. (5) The setting basically applies to the general population. (6) ARM is set based on the lowest NOAEL among all the available study data concerning endpoints for acute effects. (7) Effects of exposure during critical periods should be considered as endpoints for ARfD setting. (8) The approach for the safety coefficient is the same as that for acceptable daily intake. (9) If available, human data are acceptable as an endpoint for ARfD setting.

DOI： 10.3358/shokueishi.54.331

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD  

A 28-day repeated dose toxicity test and reproduction/developmental toxicity test for N,N'-diphenyl-p-phenylenediamine (DPPD) were conducted in [Crl:CD(SD)] SPF rats. Male and female rats were dosed with DPPD by gavage for 28 days at 0, 100, 300, or 1000 mg/kg bw/day or for a total of 42-46 days at 0, 8, 50, or 300 mg/kg bw/day. No significant adverse effects were observed in the repeated dose toxicity study up to 1000 mg/kg bw/day in both sexes. In the reproduction/developmental toxicity study, two females showed piloerection, hypothermia, and pale skin; one died and the other showed dystocia on day 23 of pregnancy at 300 mg/kg bw/day. Another female delivered only three live pups at 300 mg/kg bw/day. A significantly prolonged gestation period was observed at 50 and 300 mg/kg bw/day. The NOAELs of repeated dose toxicity and reproduction/developmental toxicity were considered to be 1000 and 8 mg/kg bw/day, respectively. (C) 2013 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.fct.2013.02.029

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：OXFORD UNIV PRESS  

Editor's Highlight: Current blood biomarkers lack sensitivity, are detectable only late after injury occurs, and lack predictive power. The present study identified novel circulating liver-specific mRNAs in plasma from rats treated with various hepatotoxicants to validate circulating liver-specific mRNAs as biomarkers for drug- induced liver injury. Liver-specific mRNAs (Alb, Ambp, Apoh, and Gc) were quantified by real-time RT-PCR in plasma from rats with single dosing of seven hepatotoxicants. Time course analysis within 24 h after dosing revealed the plasma levels of Alb and Gc mRNAs increased substantially earlier than the widely used biomarker alanine aminotransferase, suggesting that patterns of changes in circulating liver-specific mRNAs indicate the progression of liver injury. These results strongly support the reliability and usefulness of the four circulating liver-specific mRNAs as biomarkers for drug-induced liver injury.Circulating liver-specific mRNAs such as albumin (Alb) and -1-microglobulin/bikunin precursor (Ambp) have been reported to be potential biomarkers for drug-induced liver injury (DILI). We identified novel circulating liver-specific mRNAs and quantified them, together with the two previously reported mRNAs, in plasma from rats treated with various hepatotoxicants to validate circulating liver-specific mRNAs as biomarkers for DILI. Among six genes selected from the database, high liver specificity of apolipoprotein h (Apoh) and group-specific component (Gc) mRNAs were confirmed by reverse transcription (RT)-PCR and the copy numbers of these mRNAs elevated in plasma from rats treated with thioacetamide. Liver-specific mRNAs (Alb, Ambp, Apoh, and Gc) were quantified by real-time RT-PCR in plasma from rats with single dosing of seven hepatotoxicants. There were noticeable interindividual and intercompound variabilities in the severity of liver injury. The levels of four mRNAs increased almost in parallel and correlated with changes in the alanine aminotransferase (ALT) values and the hepatocellular necrosis scores at 24h after dosing. It was noteworthy that the magnitude of the increases in mRNA levels was greater than that in the ALT value. Time course analysis within 24h after dosing revealed that the timing of the increase was different among mRNA species, and the plasma levels of Alb and Gc mRNAs increased substantially earlier than the ALT values, suggesting that patterns of changes in circulating liver-specific mRNAs indicate the progression of liver injury. These results strongly support the reliability and usefulness of the four circulating liver-specific mRNAs as biomarkers for DILI.

DOI： 10.1093/toxsci/kfs340

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

We tested a category approach to predict the hepatotoxic effects of repeated doses of allyl esters using a new database for repeated-dose toxicity. Based on information on hepatotoxic mechanism of allyl acetate, the category was defined as allyl esters that are hydrolyzed to allyl alcohol. Allyl alcohol is readily oxidized to acrolein in the liver, causing hepatotoxicity. Seventeen marketed allyl esters were obtained and grouped into category by identifying or predicting allyl alcohol formation. Allyl esters with a saturated straight alkyl carboxylic acid moiety (allyl acetate, hexanoate and heptanoate as tested species, and allyl butyrate, pentanoate, octanoate, nonanoate and decanoate as untested species) are likely similar in rate of ester hydrolysis, thereby defining subcategory 1. NOAEL and LOAEL for the hepatotoxic effects were estimated at 0.12 and 0.25 mmol/kg/d for the untested species, based on those of allyl acetate. The remaining nine allyl esters with other alkyl or aromatic carboxylic acid moieties were placed in subcategory 2: their hepatotoxicity levels were not predictable due to an unclear match between their degree of structural complexity and rate of hydrolysis. Our results demonstrate the usefulness of the category approach for predicting the hepatotoxicity of untested allyl esters with saturated straight alkyl chains. (C) 2012 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.yrtph.2012.12.001

Web of Science

Scopus

PubMed

researchmap

記述言語：英語  

The available toxicity information for boron was reevaluated and four appropriate toxicity studies were selected in order to derive a tolerable daily intake (TDI) using newly proposed uncertainty factors (UFs) presented in Hasegawa et al. (2010). No observed adverse effect levels (NOAELs) of 17.5 and 8.8mgB/kg/day for the critical effect of testicular toxicity were found in 2-year rat and dog feeding studies. Also, the 95% lower confidence limit of the benchmark doses for 5% reduction of fetal body weight (BMDL05) was calculated as 44.9 and 10.3mgB/kg/day in mouse and rat developmental toxicity studies, respectively. Measured values available for differences in boron clearance between rats and humans and variability in the glomerular filtration rate (GFR) in pregnant women were used to derive chemical specific UFs. For the remaining uncertainty, newly proposed default UFs, which were derived from the latest applicable information with a probabilistic approach, and their subdivided factors for toxicokinetic and toxicodynamic variability were applied. Finally, overall UFs were calculated as 68 for rat testicular toxicity, 40 for dog testicular toxicity, 247 for mouse developmental toxicity and 78 for rat developmental toxicity. It is concluded that 0.13mgB/kg/day is the most appropriate TDI for boron, based on rat developmental toxicity. © 2012 Elsevier Inc.

DOI： 10.1016/j.yrtph.2012.10.013

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：ELSEVIER IRELAND LTD  

Renal papillary injury is a common side effect observed during nonclinical and clinical investigations in drug development. The present study aimed to identify genomic biomarkers for early and sensitive detection of renal papillary injury in rats. We hypothesized that previously identified genomic biomarkers for tubular injury might be applicable for the sensitive detection of papillary injury in rats. We selected 18 genes as candidate biomarkers for papillary injury based on previously published studies and analyzed their expression profiles by RT-PCR in each kidney region, namely the cortex, cortico-medullary junction, and papilla in various nephrotoxicity models. Comparative analysis of gene expression profiles revealed that some genes were commonly upregulated or downregulated in the renal papilla, reflecting papillary injuries induced by 2-bromoethylamine hydrobromide, phenylbutazone, or n-phenylanthranilic acid. By applying receiver operator characteristics analysis, six candidate biomarkers were identified and their usefulness was confirmed by using an independent data set. The three top-ranked genes, Timp1, Igf1, and Lamc2, exhibited the best prediction performance in an external data set with area under the curve (AUC) values of greater than 0.91. An optimized support vector machine model consisting of three genes achieved the highest AUC value of 0.99. In conclusion, even though definitive validation studies are required for the establishment of their usefulness and reliability, these identified genes may prove to be the most promising candidate genomic biomarkers of renal papillary injury in rats. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.tox.2012.09.012

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD  

Crl:CD(SD)rats were given 3-cyanopyridine by gavage at 0, 5, 30 or 180 mg/kg/day. Males were dosed for 42 days beginning 14 days before mating, and females for 40-53 days beginning 14 days before mating to day 3 of lactation, including throughout the mating and gestation periods. General toxicity, mainly liver damage, was observed in males at &gt;= 30 mg/kg/day and in females at &gt;= 5 mg/kg/day. Sertoli cell vacuolation was observed at 180 mg/kg/day, and spermatocyte damages were observed at &gt;= 30 mg/kg/day. Effects on estrous cycles, corpora lutea and implantations, and unsuccessfully mated females, despite additional mating, were observed at 180 mg/kg/day. Delayed initiation of delivery, dystocia, and deaths or mori-bundities of pregnant females were observed at 180 mg/kg/day, and only two pregnant rats delivered live pups at that dose. The NOAEL for reproductive/developmental toxicity was concluded to be 30 mg/kg/day. (C) 2012 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.reprotox.2012.10.014

Web of Science

Scopus

PubMed

researchmap

記述言語：英語  

Hypothyroidism induced by xenobiotic treatment was analyzed for possible underlying mechanism(s) on the basis of different responses of the thyroid gland and the liver, using a newly-created database of repeated-dose toxicity of 500 chemicals. Two mechanisms are proposed: direct inhibition of thyroid hormone biosynthesis in the thyroid gland, and stimulated degradation of thyroid hormone by induction of hepatic drug-metabolizing enzymes. In the database there were 10 chemicals inducing hypertrophy/ hyperplasia of follicular cells in the thyroid gland and having data on thyroid glands. On the basis of the chemical structure and information available in the literature, we judged three chemicals to be typical thioamide derivatives that act directly on the thyroid gland, and the others as non-thioamide derivatives that were unlikely to have any direct action on the thyroid gland. All these chemicals were classified into two groups using the ratios of relative weight increase rate of thyroid gland versus that of the liver. These values were at least 1.7, but 3.2 or more in the most of the cases for thioamide derivatives, and 1.2 or less for non-thioamide derivatives. This background analysis suggests the feasibility of parametersupported speculation on the possible underlying mechanism when new repeated-dose toxicity data on hypothyroidism becomes available.

DOI： 10.2131/jts.38.291

Scopus

PubMed

researchmap

記述言語：英語  

In order to develop guidelines for setting acute reference doses (ARfDs) for pesticides in Japan, we conducted simulations of ARfD settings based on evaluation reports for 201 pesticides assessed by the Food Safety Commission (FSC) in Japan over the last 8 years. Our conceptual principles were based on the concepts written by Solecki et al. (2005) and were adapted for toxicological data required in Japan. Through this process, we were able to set the ARfDs for over 90% of the 201 pesticides tested. The studies that provided the rationale for ARfD setting were primarily reproductive and developmental toxicity studies, acute neurotoxicity studies, and pharmacology studies. For approximately 30% of the pesticides simulated in the present study, it was not necessary to establish ARfDs. Some of the simulated ARfDs resulting from their endpoints may be conservative estimates, because the evaluation reports were written for acceptable daily intake settings. Thus, it was sometimes difficult to distinguish acute toxicalerts from repeated toxicities. We were unable to set an ARfD for 14 pesticides because of insufficient data on acute toxicities. This could be improved by more complete recordkeeping. Furthermore, we categorized the 201 pesticides by mechanism of action or chemical structure. Our simulation indicates that the conceptual framework presented here can be used as a basis for the development of guidelines on ARfD settings for pesticides in Japan.

DOI： 10.2131/jts.38.205

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.tox.2012.04.005

Web of Science

Scopus

researchmap

記述言語：英語   出版者・発行元：ELSEVIER IRELAND LTD  

Drug-induced renal tubular injury is a major concern in the preclinical safety evaluation of drug candidates. Toxicogenomics is now a generally accepted tool for identifying chemicals with potential safety problems. The specific aim of the present study was to develop a model for use in predicting the future onset of drug-induced proximal tubular injury following repeated dosing with various nephrotoxicants. In total, 41 nephrotoxic and nonnephrotoxic compounds were used for the present analysis. Male Sprague-Dawley rats were dosed orally or intravenously once daily. Animals were exposed to three different doses (low, middle, and high) of each compound, and kidney tissue was collected at 3, 6, 9, and 24 h after single dosing, and on days 4, 8, 15, and 29 after repeated dosing. Gene expression profiles were generated from kidney total RNA using Affymetrix DNA microarrays. Filter-type gene selection and linear classification algorithms were employed to discriminate future onset of proximal tubular injury. We identified genomic biomarkers for use in future onset prediction using the gene expression profiles determined on day 1, when most of the nephrotoxicants had yet to produce detectable histopathological changes. The model was evaluated using a five-fold cross validation, and achieved a sensitivity of 93% and selectivity of 90% with 19 probes. We also found that the prediction accuracy of the optimized model was substantially higher than that produced by any of the single genomic biomarkers or histopathology. The genes included in our model were primarily involved in DNA replication, cell cycle control, apoptosis, and responses to oxidative stress and chemical stimuli. In summary, our toxicogenomic model is particularly useful for predicting the future onset of proximal tubular injury. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.tox.2012.03.014

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2012.03.665

Web of Science

researchmap

記述言語：英語   出版者・発行元：ELSEVIER IRELAND LTD  

Phospholipid accumulation manifests as an adverse effect of cationic amphiphilic drugs in particular. Detection, however, by histopathology examination is time-consuming and may require repeated administration of compounds for several weeks. To eliminate compounds with potential for inducing phospholipidosis from the discovery pipeline, we have identified and validated a set of biomarkers for predicting the phospholipidosis-inducing potential utilizing a comprehensive rat transcriptome microarray database created by the Japanese Toxicogenomics and Toxicogenomics Informatics Projects (TGP/TGP2) together with in-house data. The set of biomarkers comprising 25 Affymetrix GeneChip probe sets was identified using genetic algorithm optimization on 24-h time-point microarray data from rats treated with single doses of hepatotoxic compounds including amiodarone, clomipramine, haloperidol, hydroxyzine, imipramine, and perhexiline. The set of novel biomarkers represents an early time-point gene-expression pattern characteristic for a condition eventually leading to phospholipidosis. This implies significant advantages in terms of time and resources over currently published biomarkers derived using repeated-dosing late time-point data. The biomarker set was validated by 11 independent compounds. Accuracy, sensitivity, and specificity values were 82%, 67%, and 100%, respectively and the area under the receiver operating characteristic curve was 0.97. These results show that the biomarker set possesses a high classification accuracy for novel compounds. Pathway analysis was carried out for the biomarkers and the detection of pathways related to lipid-metabolism was statistically significant. These pathways most probably reflect lipid metabolism changes associated with phospholipidosis supporting the validity of our novel biomarkers. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.tox.2012.02.015

Web of Science

Scopus

PubMed

researchmap

記述言語：英語  

To obtain initial information on the possible repeated-dose oral toxicity of fullerene C60, Crl:CD(SD) rats were administered fullerene C60 by gavage once daily at 0 (vehicle: corn oil), 1, 10, 100, or 1,000 mg/kg/day for 29 days, followed by a 14-day recovery period. No deaths occurred in any groups, and there were no changes from controls in detailed clinical observations, body weights, and food consumption in any treatment groups. Moreover, no treatment-related histopathological changes were found in any organs examined at the end of the administration period and at the end of the recovery period. Blackish feces and black contents of the stomach and large intestine were observed in males and females at 1,000 mg/kg/day in the treatment group. There were no changes from controls in the liver and spleen weights at the end of the administration period, but those weights in males in the 1,000 mg/kg/day group increased at the end of the recovery period. Using liquid chromatography-tandem mass spectrometry, fullerene C60 were not detected in the liver, spleen or kidney at the end of the administration period and also at the end of the recovery period. In conclusion, the present study revealed no toxicological effects of fullerene C60
however, the slight increases in liver and spleen weights after the 14-day recovery period may be because of the influence of fullerene C60 oral administration. In the future, it will be necessary to conduct a long-term examination because the effects of fullerene C60 cannot be ruled out.

DOI： 10.2131/jts.37.353

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：Japanese Society of Toxicology  

Three female Crl:CD(SD) rats/group were dosed with single wall carbon nanotube (SWCNT) or multi wall carbon nanotube (MWCNT) four times by gavage at a total of 50 mg/kg bw or 200 mg/kg bw (four equally divided doses at one-hour intervals). Acute oral doses of SWCNT and MWCNT caused neither death nor toxicological effects, and thus the oral LD50 values for SWCNT and MWCNT were considered to be greater than 50 mg/kg bw and 200 mg/kg bw, in rats respectively. Five or ten Crl:CD(SD) rats/sex were dosed with SWCNT once daily by gavage at a dose of 0 (control), 0.125, 1.25 or 12.5 mg/kg bw/day for 28 days with a 14-day recovery period (0 and 12.5 mg/kg bw/day groups). Six or twelve Crl:CD(SD) rats/sex were dosed with MWCNT once daily by gavage at a dose of 0 (control), 0.5, 5.0 or 50 mg/kg bw/day for 28 days with a 14-day recovery period (0 and 50 mg/kg bw/day groups). Based on no toxicological effects, the no observed adverse effect levels (NOAELs) of repeated dose toxicity of SWCNT and MWCNT were considered to be 12.5 mg/kg bw/day and 50 mg/kg bw/day (the highest dose tested), respectively. It was suggested that SWCNT and MWCNT dosed by gavage reached the gastro-intestinal tract as agglomerates and were mostly excreted via feces.

DOI： 10.2131/jts.37.463

Scopus

researchmap

記述言語：英語   出版者・発行元：Japanese Society of Toxicology  

The concern over endocrine disruptors prompted international establishment of a strategic framework for the identification of the estrogenic compounds. OECD has launched the Conceptual Framework tool box containing various screening and testing methods including the uterotrophic assay. The (anti)estrogenicity of 36 chemicals suspected to be estrogen-receptor interactive by in silico and/or in vitro screening in the Extended Scheme for Endocrine Disruptor Screening and Testing of the Ministry of Health, Labour and Welfare, Japan, were monitored by the uterotrophic assay using C57BL/6J ovariectomized adult female mice after a 7-day exposure by oral gavage (po) and subcutaneous injection (sc). Ethynyl estradiol was used as reference for agonist and antagonist detection. In addition, Bisphenol A (sc) and Genistein (po) were tested for the comparison to rat assays. Among the 36, 2-[Bis(4-hydroxyphenyl) methyl]benzylalcohol, 2,2',4,4'-Tetrahydroxybenzophenone, 2,4-Dihydroxybenzophenone, 3,3',5-Triiodothyroacetic acid, New fuchsin and alpha-Naphtholbenzein, showed both estrogenic agonistic and antagonistic activities
first two showed U-shaped dose-response in antagonistic studies. N,N-Diphenyl- p-phenylenediamine, 2,2'-Dihydroxy-4,4'-dimethoxybenzophenone, n-Butyl 4-hydroxybenzoate, and Reserpine were agonistic by sc. Benzo [a] pyrene, Benz [a] anthracene, Dibenz [a,h] anthracene, 2-(2H-Benzotriazol-2-yl)-4,6-di(t-pentyl)phenol, Rosemarinic acid, meta-Thymol, 6-Gingerol, Colchicine, Malachite green base, Fenbuconazole, and Lead acetate were antagonistic. The rest, i.e. n-Heptyl 4-hydroxybenzoate, Tetrazolium violet, Pravastatin sodium salt, Physostigmine, salicylate (1:1), Nordihydroguaiaretic acid, o-Cresolphthalein, 1,3-Dinitrobenzene, C.I. Pigment orange, Tetrabromobisphenol- A, 2-Hydroxy-4-methoxybenzophenone, Ethylparaben, Propyl p-hydroxybenzoate, Kaempferol, 2-(2-Benzotriazolyl)-p-cresol and Phenolphthalein were negative for both effects. Taking together with in silico/ in vitro screening, the result suggested that the ovariectomized mouse uterotrophic bioassay has sufficient performance comparable to rat for the screening of (anti)estrogenicity of various chemicals.

DOI： 10.2131/jts.37.879

Scopus

PubMed

researchmap

記述言語：英語  

An important technology used in toxicogenomic drug discovery research is the microarray, which enables researchers to simultaneously analyze the expression of a large number of genes. To build a database and data analysis system for use in assessing the safety of drugs and drug candidates, in 2002 we conducted a 5-year collaborative study in the Toxicogenomics Project (TGP1) in Japan. Experimental data generated by such studies must be validated by different laboratories for robust and accurate analysis. For this purpose, we conducted intra- and inter-laboratory validation studies with participating companies in the second collaborative study in the Toxicogenomics Project (TGP2). Gene expression in the liver of rats treated with acetaminophen (APAP) was independently examined by the participating companies using Affymetrix GeneChip microarrays. The intra- and inter-laboratory reproducibility of the data was evaluated using hierarchical clustering analysis. The toxicogenomics results were highly reproducible, indicating that the gene expression data generated in our TGP1 project is reliable and compatible with the data generated by the participating laboratories.

DOI： 10.2131/jts.37.791

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：JAPANESE PHARMACOLOGICAL SOC  

Web of Science

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2011.05.351

Web of Science

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2011.05.961

Web of Science

researchmap

記述言語：日本語   出版者・発行元：(一社)日本毒性学会  

【背景・目的】Ames試験で陰性となった化合物の発がん性はがん原性試験等を実施しなければ見極めることができず、費用や期間の面から簡便かつ短期間で実施可能な評価方法の確立が望まれている。本研究ではトキシコゲノミクスプロジェクトにおいて構築されたデータベース（TG-GATEs）を用いて、細胞障害性の非遺伝毒性肝発がん化合物のリスク評価マーカの探索および、予測モデルの構築を行い、その有用性を検討した。【方法】6週齢の雄性ラットに各種化合物（低・中・高用量）を単回・反復投与し、投与開始後3・6・9・24時間後、あるいは4・8・15・29日目に屠殺した。その後、Affymetrix社製のGeneChipを用いて肝臓の網羅的遺伝子発現データを取得し、次の手順で判別分析を行った。(i)「Ames試験陰性、且つラットで細胞障害性肝発がんを誘発することが知られている6化合物の反復29日の最高投与量」を正例とし、「ラットで肝発がんを誘発しないことが知られている54化合物の単回3～24時間および反復4～29日の最高投与量」を負例に設定した。(ii) 正負例間での遺伝子発現値の倍率変化、Mann-WhitneyのU統計量、SVM Marginを指標として遺伝子の総合ランキングを算出した。(iii) 抽出した遺伝子を使用し、SVMによりモデルを構築した。モデルの検証には5-fold Cross Validationを用い、ROC解析により最適遺伝子数を決定した。【結果】ランキング上位の9遺伝子を使用した際にモデルの判別性能が最大となり、感度は約99%、特異度は約97%であった。選抜した遺伝子には発がんとの関連性が報告されている&lt;I&gt;Cd276&lt;/I&gt;や&lt;I&gt;Cdh13&lt;/I&gt;などの既知遺伝子や、細胞増殖・細胞死・DNA修復関連の遺伝子が含まれていた。また、これら遺伝子は、細胞障害性の遺伝毒性肝発がん物質でも共通の発現変動を示した。【結論】我々の構築した予測モデルは、化合物の肝発がんリスクを早期に評価することが可能であり、創薬の初期段階において有用であると考えられた。

CiNii Article

J-GLOBAL

researchmap

記述言語：英語   出版者・発行元：Wiley-Blackwell  

Biotechnology advances have provided novel methods for the risk assessment of chemicals. The application of microarray technologies to toxicology, known as toxicogenomics, is becoming an accepted approach for identifying chemicals with potential safety problems. Gene expression profiling is expected to identify the mechanisms that underlie the potential toxicity of chemicals. This technology has also been applied to identify biomarkers of toxicity to predict potential hazardous chemicals. Ultimately, toxicogenomics is expected to aid in risk assessment. The following discussion explores potential applications and features of the Japanese toxicogenomics project.

DOI： 10.1002/9783527634705.ch3b

Scopus

researchmap

記述言語：日本語   出版者・発行元：日本毒性学会  

薬剤誘発性腎障害は，創薬において最も注意すべき副作用の一つである．従って，創薬研究の初期段階に，医薬品候補化合物の腎障害誘発リスクをいち早く見極め，腎毒性リスクのない化合物を効率的に選び出すことが肝要である．今回，トキシコゲノミクス・インフォマティクスプロジェクトにおいて構築された大規模トキシコゲノミクスデータベース（TG-GATEs）を使用して，薬剤誘発性腎尿細管障害の診断マーカーの探索を実施した．【方法】6週齢の雄ラットに，薬剤（低，中，高用量）を1日1回，最長28日間反復投与し，投与開始後，4，8，15，29日目に屠殺して腎臓を採取した．腎臓の病理検査を実施すると共に，網羅的遺伝子発現解析を実施した．【結果及び考察】病理組織検査の結果に基づき，反復投与により尿細管障害が認められる21化合物の高用量群サンプルを正例，障害の認められない41化合物の低用量群サンプル及び腎毒性の陰性対照である8化合物の高用量群サンプルを負例とし，filter-typeの遺伝子選択法を適用してマーカー候補遺伝子（feature gene）を抽出した後，これを用いて線形判別器を構築した．5-fold cross validationによる判別精度検証を実施した結果，偽陽性率が約10%のとき，検出力は90%となった．次に，学習に用いなかった高用量，中用量群サンプルをテストセットとして構築した判別器を適用し，毒性予測を行った．その結果，多くの化合物において，病理変化が見られる時間よりも早い時点，あるいは，低い用量で毒性を検出できた．以上，今回構築した腎毒性の判別モデルは，薬剤誘発性腎障害の有無を高感度に検出する有用な手段になり得ると考えられた．

CiNii Article

J-GLOBAL

researchmap

記述言語：日本語   出版者・発行元：(一社)日本毒性学会  

【背景・目的】トキシコゲノミクス・インフォマティクスプロジェクト（TGP2）は国立医薬品食品衛生研究所、（独）医薬基盤研究所および製薬企業13社によって進められており、TGP第一期で取得した約150化合物のラット肝遺伝子発現データ及び関連する毒性学的データを用いて安全性バイオマーカーの探索を行っている．本発表では、TGPデータベースを用い、ストレス応答性転写因子Nrf2制御下遺伝子のラット肝における発現変化について報告を行う．【方法】150化合物を投与開始時６週齢の雄性SDラットにそれぞれ単回および28日間反復投与を行い計8時点で肝臓を採取した．遺伝子発現解析には、Affymetrix GeneChip Rat 230 2.0を用いた．【結果】文献情報に基づきNrf2制御下遺伝子のリスト化を行い、酸化ストレスの既知マーカー、グルタチオン代謝関連遺伝子、プロテアソーム構成遺伝子等を含む93プローブセットを解析対象とし、それらの発現変化が顕著であった単回投与後24時間のラット肝のGeneChipデータを用いて解析を行った．発現変化が大きい化合物には、フルタミドやクマリン、ニメスリド等、酸化ストレスや反応性代謝物の生成が報告されている化合物が含まれていた．また、ニメスリドのようにラット28日間反復投与試験では顕著な肝障害が認められなかったものの臨床では肝障害報告がある化合物についても、Nrf2制御下遺伝子は単回投与で大幅に変動していることから、Nrf2制御下遺伝子の発現変化を調べることにより酸化ストレスや反応性代謝物を介した肝障害リスクを短期で捉えることができる可能性が示唆された．

CiNii Article

J-GLOBAL

researchmap

記述言語：日本語   出版者・発行元：(一社)日本毒性学会  

researchmap

記述言語：日本語   出版者・発行元：(一社)日本毒性学会  

薬剤誘発性腎障害は，創薬において最も注意すべき副作用の一つである．従って，創薬研究の初期段階に，医薬品候補化合物の腎障害誘発リスクをいち早く見極め，安全な化合物を効率的に選び出すことが肝要である．今回，トキシコゲノミクス・インフォマティクスプロジェクトにおいて構築された大規模トキシコゲノミクスデータベース（TG-GATEs）を使用して，単回投与毒性試験において活用可能な薬剤誘発性腎尿細管障害の予測マーカーの探索を実施した．【方法】6週齢の雄性ラットに，種々の化合物（低，中，高用量）を1日1回，最長28日間反復投与し，投与開始後，1，4，8，15，29日目に屠殺した．採取した腎臓の病理検査を実施すると共に，Affymetrix社製のGeneChipを用いて網羅的遺伝子発現解析を実施した．【結果】反復投与時（投与後4 から29日目）の病変の有無によりアンカリングした投与後1日目の遺伝子発現データ（10/14化合物が単回投与後翌日の時点では病変なし）に対してfilter-typeの遺伝子選択法を適用し，マーカー候補遺伝子（feature gene）を抽出した後，これを用いて線形判別器を構築した．5-fold cross validationによる判別精度検証を実施した結果，偽陽性率が約10%のとき，検出力は約93%となった．feature geneには，Kim1，Timp1，Clusterin等良く知られた既知の腎尿細管障害マーカーに加え，新規のマーカー候補遺伝子も幾つか含まれていた．また，これらの既知マーカーを単独で判別に用いた時の予測精度と比較して，今回構築した複数個の遺伝子を用いた判別器で大幅に高い予測精度が得られた．【結論】今回構築した腎毒性の判別モデルは，薬剤誘発性腎尿細管障害の有無を早期に予測する有用な手段になり得ると考えられた．

CiNii Article

J-GLOBAL

researchmap

記述言語：英語   出版者・発行元：SAGE PUBLICATIONS LTD  

We have constructed a large-scale transcriptome database of rat liver treated with various drugs. In an effort to identify a biomarker for the diagnosis of elevated total bilirubin (TBIL) and direct bilirubin (DBIL), we extracted 59 probe sets of rat hepatic genes from the data for seven typical drugs, gemfibrozil, phalloidin, colchicine, bendazac, rifampicin, cyclosporine A, and chlorpromazine, which induced this phenotype from 3 to 28 days of repeated administration in the present study. Principal component analysis (PCA) using these probes clearly separated dose-and time-dependent clusters in the treated groups from their controls. Eighteen more drugs in the database, reported to elevate TBIL and DBIL, were estimated by PCA using these probe sets. Of these, 12 drugs, that is methapyrilene, thioacetamide, ticlopidine, ethinyl estradiol, alpha-naphthylisothiocyanate, indomethacin, methyltestosterone, penicillamine, allyl alcohol, aspirin, iproniazid, and isoniazid were also separated from the control clusters, as were the seven typical drugs causing elevation of TBIL and DBIL. The principal component 1 (PC1) value showed high correlation with TBIL and DBIL. In the cases of colchicine, bendazac, chlorpromazine, gemfibrozil, and phalloidin, the possible elevation of TBIL and DBIL could be predicted by expression of these genes 24 h after single administration. We conclude that these identified 59 probe sets could be useful to diagnose the cause of elevation of TBIL and DBIL, and that toxicogenomics would be a promising approach for prediction of this type of toxicity.

DOI： 10.1177/0960327109104528

Web of Science

Scopus

PubMed

researchmap

記述言語：日本語   出版者・発行元：(一社)日本毒性学会  

【目的】トキシコゲノミクス・インフォマティクスプロジェクトにおいてSVM等の判別器と病理所見を用いた遺伝子発現プロファイルの分類によって毒性マーカー遺伝子が同定されつつある。これらマーカー遺伝子のパスウェイ等のコンテキストを調べるため、大規模トキシコゲノミクスデータベースを使用して、網羅的な解析を検討した。 【方法】各サンプルを表現型ではなく実験条件によって分類、比較した。実験条件で分類することで、例えば、投与量と投与時間を固定して化合物を変えることによって、遺伝子発現の変化の原因を化合物の違いに絞ることができる。さらに、遺伝子単位ではなくパスウェイ単位で比較し、有意差を計算することで毒性の特異性とは関係のない遺伝子の影響を減らすことができる。例えば、高投与量と低投与量のサンプルを比較した場合、 タンパク合成系の遺伝子の多くに発現変動が観察されるが、パスウェイ単位で比較することでその数の重みは軽減される。パスウェイの有意差の算出にはGSEA法を用いた。GSEA法では、遺伝子の発現差によるランキングとSN比を用いて、２つのサンプル間の特定の遺伝子セット（パスウェイ）の有意差を算出する。また、これらの遺伝子セットのプロファイルに基づいたサンプル間の関係の可視化についても検討した。 【結果】上記方法によっていくつかの毒性マーカー候補が有意差のある遺伝子セット上に観察され、そのコンテキストを推測することができた。

CiNii Article

J-GLOBAL

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2008.06.567

Web of Science

researchmap

記述言語：英語   出版者・発行元：SAGE PUBLICATIONS LTD  

One expected result from toxicogenomics technology is to overcome the barrier because of species-specific differences in prediction of clinical toxicity using animals. The present study serves as a model case to test if the well-known species-specific difference in the toxicity of coumarin could be elucidated using comprehensive gene expression data from rat in-vivo, rat in-vitro, and human in-vitro systems. Coumarin 150 mg/kg produced obvious pathological changes in the liver of rats after repeated administration for 7 days or more. Moreover, 24 h after a single dose, we observed minor and transient morphological changes, suggesting that some early events leading to hepatic injury occur soon after coumarin is administered to rats. Comprehensive gene expression changes were analyzed using an Affymetrix GeneChip (R) approach, and differentially expressed probe sets were statistically extracted. The changes in expression of the selected probe sets were further examined in primary cultured rat hepatocytes exposed to coumarin, and differentially expressed probe sets common to the in-vivo and in-vitro datasets were selected for further study. These contained many genes related to glutathione metabolism and the oxidative stress response. To incorporate human data, human hepatocyte cultured cells were exposed to coumarin and changes in expression of the bridging gene set were examined. In total, we identified 14 up-regulated and 11 down-regulated probe sets representing rat-human bridging genes. The overall responsiveness of these genes to coumarin was much higher in rats than humans, consistent with the reported species difference in coumarin toxicity. Next, we examined changes in expression of the rat-human bridging genes in cultured rat and human hepatocytes treated with another hepatotoxicant, diclofenac sodium, for which hepatotoxicity does not differ between the species. Both rat and human hepatocytes responded to the marker genes to the same extent when the same concentrations of diclofenac sodium were exposed. We conclude that toxicogenomics-based approaches show promise for overcoming species-specific differences that create a bottleneck in analysis of the toxicity of potential therapeutic treatments.

DOI： 10.1177/0960327107087910

Web of Science

Scopus

PubMed

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：JAPANESE PHARMACOLOGICAL SOC  

Web of Science

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2006.06.015

Web of Science

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ELSEVIER IRELAND LTD  

DOI： 10.1016/j.toxlet.2006.07.277

Web of Science

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   掲載種別：研究発表ペーパー・要旨（国際会議）   出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE  

Web of Science

researchmap

記述言語：日本語   出版者・発行元：Food Hygienic Society of Japan  

A 52-week study of oral-repeated-dose toxicity for the extraction powder of Gymnema sylvestre (GS), Indian-native genus, Metaplexis japonica, was conducted in both genders of Wistar rats. The rats were administered a graded dose of GS at 0.01, 0.10 and 1.00% of basal powder diet, along with a group fed solely with the basal powder diet without GS, for 52 weeks. General conditions were recorded daily. Body weights and food consumptions were recorded weekly up to 12 weeks, and thereafter at longer intervals. At 26 weeks, for an intermediate examination, and 52 weeks, for the final examination, animals were subjected to hematology, serum chemistry, and pathological examination. None of the animals died in the period up to 52 weeks. No exposure-related changes in body-weight, in the food consumption, in the hematological examinations, or in the serum biochemical examinations were recognized. No histopathological alterations were seen. Thus, it was concluded that there was no toxic effect in rats treated with GS at up to 1.00% in the diet for 52 weeks. The no-observable-effect level from this study is 1.00% GS, ie., 504 mg/kg/day for male and 563 mg/kg/day for female as mean daily intake, for 52 weeks.

DOI： 10.3358/shokueishi.45.8

Scopus

PubMed

researchmap

記述言語：日本語   出版者・発行元：秀潤社  

CiNii Article

CiNii Books

researchmap

その他リンク： http://search.jamas.or.jp/link/ui/2004271189

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：JAPAN SOC ANALYTICAL CHEMISTRY  

Because concern over endocrine disrupting reactions caused by chemicals to human and animals is growing, a rapid and reliable screening assay for endocrine disrupting chemicals is required. We have developed an in vitro screening assay based on a hormone receptor mechanism using a surface plasmon resonance (SPR) sensor. When a DNA fragment containing a sequence of the estrogen response element (ERE) is immobilized on a sensor chip of a SPR sensor and an estrogen receptor a(ER) is injected over the sensor chip, the interaction of ER and ERE can be monitored in real time. In the presence of a chemical with estrogenic activity, the ER-ERE interaction is enhanced and the kinetic parameters are altered. We have validated the assay in terms of its specificity, dose dependency, optimal reaction conditions and reproducibility. It has been shown that the assay is very reliable as a rapid and quantitative screening method to judge the estrogenic activities of chemicals.

DOI： 10.2116/bunsekikagaku.51.389

Web of Science

Scopus

researchmap

記述言語：英語   出版者・発行元：ELSEVIER SCI IRELAND LTD  

Toluene is a widely abused inhaled solvent. This study was designed to determine whether toluene abuse affects the reproductive functions or general health of males. Seven-week-old male Sprague-Dawley rats were exposed to toluene vapor inhalation (0, 4000, or 6000 ppm; 2 h/day) daily for 5 weeks. Exposure-related suppression of body weight gain and food consumption were observed. Salivation and lacrimation were observed during exposure periods and intensified with repeated exposure. Rats exposed to 6000 ppm toluene had decreased spleen and thymus weights, as well as suppressed lymphocyte counts. In 6000 ppm group, the epididymal sperm counts, sperm motility, sperm quality and in vitro penetrating ability to zona-free hamster eggs were significantly reduced, while no exposure-related changes in the testes weight or spermatogenesis within testes were detected. Tail-less sperm heads were seen within zona-free eggs incubated with sperm from rats exposed to 6000 ppm toluene, but not control rats. No significant changes were observed in serum luteinizing hormone, follicle-stimulating hormone, or testosterone levels following 1 month of exposure to 6000 ppm toluene. These results indicate that high concentrations of toluene may directly target sperm in the epididymis and disrupt sperm maturation. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.

DOI： 10.1016/S0300-483X(99)00120-1

Web of Science

Scopus

PubMed

researchmap

記述言語：日本語  

A 13-week oral repeated dose toxicity study of haematococcus color, a food additive mainly composed of astaxanthin, was conducted in male and female F344 rats. Rats were randomly divided into 4 groups each consisting of 10 males and 10 females and given CRF-1 powder diet containing 0%, 0.025%, 0.075%, and 0.25% haematococcus color, correspond to 0%, 0.5%, 1.5%, and 5% as the product. None of the animals died during the administration period. There were no exposure-related changes in body weight gain or food consumptions. Serum biochemical examinations showed dose-related increase in cholesterol, but the differences were slight and not defined as an adverse effect. No effects related to treatment were noted in hematological examinations and organ weights, and no abnormalities that could be ascribed to exposure to heamatococcus color were observed in histopathological examinations. In conclusion, ingestion of haematococcus color in the diet for 13 weeks does not cause any toxicological changes in F344 rats.

Scopus

PubMed

researchmap

記述言語：日本語   出版者・発行元：FOOD HYG SOC JPN  

A subchronic toxicity study of pecan nut color was performed using F344 rats of both genders. Pecan nut color, a flavonoid extrcated from the coat of pecan nuts (Carya pecan ENGL. et GRAEBN.), is permitted for use as a food color by the Ministry of Health and Walfare, Japan. The product containing 60% dextrin (added in the process of manufacture) was used in the experiment. Rats were administered pecan nut color at concentrations of 0% (basal diet, control group), 0.5%, 3.0% and 5.0% in the basal powder diet for 90 days. Rats in the vehicle control group were given dextrin at the concentration of 3.0% in the same manner as used for the experimental groups. No significant changes related to pecan nut color or dextrin were found in body weight or food consumption throughout the observation period, or in hematology, serum chemistry or organ weights at autopsy. Furthermore, neither gross nor histological examination revealed any adverse effect or significant difference from the control. IL is concluded that feeding of diet containing pecan nut color at a concentration of 5.0% (1,287 mg/kg/day for males and 1,344 mg/kg/day for females as mean intake of pecan nut color without dextrin) for 90 days has no adverse effect in rats.

DOI： 10.3358/shokueishi.39.6_375

Web of Science

Scopus

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：Japanese Society of Toxicology  

A control survey was conducted to check the accuracy of automated analyzers used in the evaluation of clinical chemistry parameters in nonclinical toxicology studies. Pooled serum samples from male Sprague- Dawley rats were delivered refrigerated to each facility 98 laboratory facilities throughout Japan within 18 hours after sample preparation and analyzed. Commercially available normal human serum samples from a single lot were also analyzed at the same time. Survey results were divided into three categories. (1) Parameters with small coefficient of variation (CV) values for both rat and human serum samples included protein, glucose, cholesterol (CHO), urea nitrogen (UN), sodium (Na), potassium (K), chloride (Cl), calcium (Ca), and inorganic phosphate (IP). Definition of normal values in rats should be straight forward for these parameters. (2) Parameters with large CV values, but with a relatively good correlation between rat and human values include triglycerides (TG), glutamic oxaloacetic transaminase/aspartate aminotransferase (GOT/AST), glutamic pyruvic transaminase/alanine aminotransferase (GPT/ALT), and alkaline phosphatase (ALP). Measurements based on different principles gave different mean values, and this values contributed to the increase in CV values. Assessment of normal values would require a consideration of the measurement principles. (3) Parameters with large CV values only in rat serum samples included albumin (albumin/globulin ratio: A/G ratio), creatinine (CRE), and total bilirubin(BIL). Reactivity was different in rat albumin (ALB), depending on the reagents used. This difference needs to be corrected with values available by electrophoresis, or adjusted by rat ALB values, because of the lack of an appropriate measurement method. The enzyme method gave low values for rat CRE, which suggests the need for further examination of this method. The BIL values were extremely low in rat samples. It seems to be necessary to select appropriate methods to measure clinical pathology parameters correctly for rats. There was no deviation in values due solely to the mechanical operations of the analytical equipment. Non-standard initial settings of the equipment (equipment originally intended for human samples, but now applied to animal samples) was the main cause of the wide range of analytical values seen.

DOI： 10.2131/jts.22.25

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

記述言語：英語   出版者・発行元：日本毒性学会  

CiNii Article

CiNii Books

researchmap

A survey was conducted to determine the accuracy and quality control of automated haematology analysers used in non-clinical toxicity studies. Pooled blood samples from male Sprague-Dawley rats were distributed to 98 laboratory facilities throughout Japan, the samples being delivered under refrigeration to each facility within 18 h of sample preparation. At each facility, the samples were analysed within 4 h of receipt. Commercially available normal human blood samples from a single lot were also analysed at the same time. Most haematological results were within the mean ± 3SD (standard deviation), but some facilities gave either high or low values consistently for both human and rat samples. No facility gave high or low values to certain parameters sporadically, which suggests no problem with the accuracy of the equipment. However, it was suspected that there would be some problem in comparing analytical values determined in a unique way by specific equipment design. The use of certain equipment resulted, in rat haematocrit values in particular, being either too high or too low. In these cases, it was deemed necessary to make some adjustments or calibration changes. There were also platelet values with a &#039;plus drift&#039; which was apparently due to contamination with, or failure to identify small red blood cells (RBC). There was no deviation in values which could be attributed solely to the mechanical operation of any of the analytical equipment. Non-standard, initial setting up of the equipment (originally intended for human use, but now used for a variety of animal species) has been recognised as the main cause for a wider range of the analytical values seen. The results of this survey suggest that it may be necessary to review equipment calibration at each facility, and to re-establish the historical background data. © 1996 Springer-Verlag London Limited.

Scopus

researchmap

記述言語：英語  

Male and female Sprague-Dawley rats were exposed to toluene vapor at 600 and 2000 ppm for 6 h/day, and effects on their fertility were investigated. Females were exposed from 14 days before mating until day 7 of gestation. Males were exposed for a total of 90 days, including the mating period
treatment was begun 60 days before pairing, and toxicity with respect to testicular and reproductive functions was examined. In females of the 2000 ppm-treated group, salivation and lacrimation that may have been caused by CNS depression were observed starting 20 days after exposure. Although no abnormalities were seen in mating behavior or fertility, fetal mortality and the number of dams with dead fetuses increased in the 2000 ppm group. In the males exposed to 2000 ppm toluene for 90 days, an increase in kidney weights and a decrease in thymus weights were observed. Basophilic changes and necrosis of kidney tubules were greater at the higher exposure level. Additionally, decreases in the weights of the epididymides and spermatic count were observed, indicating toxicity of toluene to the male reproductive system in vivo for the first time. In conclusion, embryo-fetal toxic effects were apparent in female rats exposed to toluene before and during the early stage of pregnancy. Subacute exposure to a high level (2000 ppm) of toluene vapor elicited mild toxic changes in the kidneys, thymus, and reproductive organs of males. Toxic effects on fertility and reproduction were thus demonstrated not only in females but also in males exposed to toluene vapor in the present study.

Scopus

PubMed

researchmap

記述言語：英語   出版者・発行元：SPRINGER VERLAG  

A survey was conducted to determine the accuracy and quality control of automated haematology analysers used in non-clinical toxicity studies. Pooled blood samples from male Sprague-Dawley rats were distributed to 98 laboratory facilities throughout Japan, the samples being delivered under refrigeration to each facility within 18 h of sample preparation. At each facility, the samples were analysed within 4 h of receipt. Commercially available normal human blood samples from a single lot were also analysed at the same time. Most haematological results were within the mean +/- 3SD (standard deviation), but some facilities gave either high or low values consistently for both human and rat samples. No facility gave high or low values to certain parameters sporadically, which suggests no problem with the accuracy of the equipment. However, it was suspected that there would be some problem in comparing analytical values determined in a unique way by specific equipment design. The use of certain equipment resulted, in rat haematocrit values in particular, being either too high or too low. In these cases, it was deemed necessary to make some adjustments or calibration changes. There were also platelet values with a 'plus drift' which was apparently due to contamination with, or failure to identify small red blood cells (RBC). There was no deviation in values which could be attributed solely to the mechanical operation of any of the analytical equipment.
Non-standard, initial setting up of the equipment (originally intended for human use, but now used for a variety of animal species) has been recognised as the main cause for a wider range of the analytical values seen. The results of this survey suggest that it may be necessary to review equipment calibration at each facility, and to re-establish the historical background data.

DOI： 10.1007/BF00368455

Web of Science

Scopus

researchmap

記述言語：英語   出版者・発行元：Japanese Society of Toxicology  

Toluene is a widely used solvent in industry which is the subject of abuse among the younger generation. A teratogenicity study of toluene by inhalation exposure was carried out in Sprague-Dawley rats and the effects on dams, fetuses and offspring were assessed. Pregnant females were exposed to 600 or 2000 ppm toluene for 6 h/day from day 7 to day 17 of pregnancy. The control group inhaled conditioned clean air under the same exposure conditions. Maternal exposure to 2000 ppm toluene caused significant toxic effects such as body weight suppression of dams and offspring, high fetal mortality and embryonic growth retardation, but no external, internal or skeletal anomalies were observed in the fetuses of any treated group. In addition, there were no differences in the results of pre- and postweaning behavioral tests of the offspring. However, no toxic or teratogenic changes which could be related to toluene exposure were apparent in the 600 ppm group. Further studies are warranted with toluene at higher concentrations applied during the period of organogenesis.

DOI： 10.2131/jts.20.109

Scopus

PubMed

researchmap

記述言語：英語  

The conductance caused by translocation of various phosphonium cations across phospholipid (from soybean) bilayer membrane was measured. Phosphonium cations used were tetraphenylphosphonium (TPP+) and triphenylalkylphosphonium cations formulated as (Phe)3−P+-(CH2)nCH3 (n = 0–5). The conductance was dependent on voltage applied externally to the membrane in accordance with a theory developed by previous authors. Using the theory, values of βki were determined, where β and ki are a linear partition coefficient and a rate constant of transmembrane ion transport, respectively. Since βki depended on the phosphonium ion concentration, values extrapolated to infinite dilution, (βki)0, were determined. Temperature dependence of (βki)0 allowed us to estimate the activation energy of transport, Ea. For TPP+, thermodynamic values obtained were consistent with values calculated by Flewelling and Hubbell [(1986) Biophys. J. 49, 541–552]. When (Phe)3−P+-(CH2)nCH3 (n = 0–5) were used, Ea depended on the odd or even of n. This “odd and even” pattern was observed in a variety of phenomena such as solubility in water, equivalent ionic conductivity in water, and 31P NMR chemical shift. © 1994, American Chemical Society. All rights reserved.

DOI： 10.1021/bi00180a027

Scopus

PubMed

researchmap

記述言語：英語  

Membrane transport of tetraphenylphosphonium and its homologues through the planar phospholipid bilayer: concentration dependence and mutually competitive inhibition in membrane passive transport

DOI： 10.1002/jps.2600820107

Scopus

PubMed

researchmap